<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism - Kakkos, S - 2022 | Cochrane Library</title> <meta content="Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism - Kakkos, S - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005258.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism - Kakkos, S - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005258.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005258.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism" name="citation_title"/> <meta content="Stavros Kakkos" name="citation_author"/> <meta content="University of Patras Medical School" name="citation_author_institution"/> <meta content="kakkos@upatras.gr" name="citation_author_email"/> <meta content="George Kirkilesis" name="citation_author"/> <meta content="University of Patras Medical School" name="citation_author_institution"/> <meta content="Joseph A Caprini" name="citation_author"/> <meta content="George Geroulakos" name="citation_author"/> <meta content="Andrew Nicolaides" name="citation_author"/> <meta content="University of Nicosia Medical School" name="citation_author_institution"/> <meta content="Gerard Stansby" name="citation_author"/> <meta content="Freeman Hospital" name="citation_author_institution"/> <meta content="Daniel J Reddy" name="citation_author"/> <meta content="Wayne State University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD005258.pub4" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/01/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005258.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005258.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005258.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [therapeutic use]; Hemorrhage; Leg; *Pulmonary Embolism [prevention &amp; control]; *Venous Thromboembolism [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005258.pub4&amp;doi=10.1002/14651858.CD005258.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="xcg9958b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005258\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005258\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","th","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005258.pub4",title:"Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism",firstPublishedDate:"Jan 28, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005258.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005258.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005258.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005258.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005258.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005258.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005258.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005258.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005258.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005258.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11627 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005258.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0068"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-sec-0062"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/appendices#CD005258-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/table_n/CD005258StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/table_n/CD005258StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Stavros Kakkos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0005">George Kirkilesis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0006">Joseph A Caprini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0007">George Geroulakos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0008">Andrew Nicolaides</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0009">Gerard Stansby</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information#CD005258-cr-0010">Daniel J Reddy</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information/en#CD005258-sec-0082">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 January 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005258.pub4">https://doi.org/10.1002/14651858.CD005258.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005258-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005258-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005258-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005258-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005258-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD005258-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005258-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005258-abs-0001" lang="en"> <section id="CD005258-sec-0001"> <h3 class="title" id="CD005258-sec-0001">Background</h3> <p>It is generally assumed by practitioners and guideline authors that combined modalities (methods of treatment) are more effective than single modalities in preventing venous thromboembolism (VTE), defined as deep vein thrombosis (DVT) or pulmonary embolism (PE), or both. This is the second update of the review first published in 2008. </p> </section> <section id="CD005258-sec-0002"> <h3 class="title" id="CD005258-sec-0002">Objectives</h3> <p>The aim of this review was to assess the efficacy of combined intermittent pneumatic leg compression (IPC) and pharmacological prophylaxis compared to single modalities in preventing VTE. </p> </section> <section id="CD005258-sec-0003"> <h3 class="title" id="CD005258-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, CINAHL, and AMED databases, and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 18 January 2021. We searched the reference lists of relevant articles for additional studies.  </p> </section> <section id="CD005258-sec-0004"> <h3 class="title" id="CD005258-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) or controlled clinical trials (CCTs) of combined IPC and pharmacological interventions used to prevent VTE compared to either intervention individually. </p> </section> <section id="CD005258-sec-0005"> <h3 class="title" id="CD005258-sec-0005">Data collection and analysis</h3> <p>We independently selected studies, applied Cochrane's risk of bias tool, and extracted data. We resolved disagreements by discussion. We performed fixed‐effect model meta‐analyses with odds ratios (ORs) and 95% confidence intervals (CIs). We used a random‐effects model when there was heterogeneity. We assessed the certainty of the evidence using GRADE. The outcomes of interest were PE, DVT, bleeding and major bleeding. </p> </section> <section id="CD005258-sec-0006"> <h3 class="title" id="CD005258-sec-0006">Main results</h3> <p>We included a total of 34 studies involving 14,931 participants, mainly undergoing surgery or admitted with trauma. Twenty‐five studies were RCTs (12,672 participants) and nine were CCTs (2259 participants). Overall, the risk of bias was mostly unclear or high. We used GRADE to assess the certainty of the evidence and this was downgraded due to the risk of bias, imprecision or indirectness. </p> <p>The addition of pharmacological prophylaxis to IPC compared with IPC alone reduced the incidence of symptomatic PE from 1.34% (34/2530) in the IPC group to 0.65% (19/2932) in the combined group (OR 0.51, 95% CI 0.29 to 0.91; 19 studies, 5462 participants, low‐certainty evidence). The incidence of DVT was 3.81% in the IPC group and 2.03% in the combined group showing a reduced incidence of DVT in favour of the combined group (OR 0.51, 95% CI 0.36 to 0.72; 18 studies, 5394 participants, low‐certainty evidence). The addition of pharmacological prophylaxis to IPC, however, increased the risk of any bleeding compared to IPC alone: 0.95% (22/2304) in the IPC group and 5.88% (137/2330) in the combined group (OR 6.02, 95% CI 3.88 to 9.35; 13 studies, 4634 participants, very low‐certainty evidence). Major bleeding followed a similar pattern: 0.34% (7/2054) in the IPC group compared to 2.21% (46/2079) in the combined group (OR 5.77, 95% CI 2.81 to 11.83; 12 studies, 4133 participants, very low‐certainty evidence). </p> <p>Tests for subgroup differences between orthopaedic and non‐orthopaedic surgery participants were not possible for PE incidence as no PE events were reported in the orthopaedic subgroup. No difference was detected between orthopaedic and non‐orthopaedic surgery participants for DVT incidence (test for subgroup difference P = 0.19).  </p> <p>The use of combined IPC and pharmacological prophylaxis modalities compared with pharmacological prophylaxis alone reduced the incidence of PE from 1.84% (61/3318) in the pharmacological prophylaxis group to 0.91% (31/3419) in the combined group (OR 0.46, 95% CI 0.30 to 0.71; 15 studies, 6737 participants, low‐certainty evidence). The incidence of DVT was 9.28% (288/3105) in the pharmacological prophylaxis group and 5.48% (167/3046) in the combined group (OR 0.38, 95% CI 0.21 to 0.70; 17 studies; 6151 participants, high‐certainty evidence). Increased bleeding side effects were not observed for IPC when it was added to anticoagulation (any bleeding: OR 0.87, 95% CI 0.56 to 1.35, 6 studies, 1314 participants, very low‐certainty evidence; major bleeding: OR 1.21, 95% CI 0.35 to 4.18, 5 studies, 908 participants, very low‐certainty evidence). </p> <p>No difference was detected between the orthopaedic and non‐orthopaedic surgery participants for PE incidence (test for subgroup difference P = 0.82) or for DVT incidence (test for subgroup difference P = 0.69). </p> </section> <section id="CD005258-sec-0007"> <h3 class="title" id="CD005258-sec-0007">Authors' conclusions</h3> <p>Evidence suggests that combining IPC with pharmacological prophylaxis, compared to IPC alone reduces the incidence of both PE and DVT (low‐certainty evidence). Combining IPC with pharmacological prophylaxis, compared to pharmacological prophylaxis alone, reduces the incidence of both PE (low‐certainty evidence) and DVT (high‐certainty evidence). We downgraded due to risk of bias in study methodology and imprecision. Very low‐certainty evidence suggests that the addition of pharmacological prophylaxis to IPC increased the risk of bleeding compared to IPC alone, a side effect not observed when IPC is added to pharmacological prophylaxis (very low‐certainty evidence), as expected for a physical method of thromboprophylaxis. The certainty of the evidence for bleeding was downgraded to very low due to risk of bias in study methodology, imprecision and indirectness. The results of this update agree with current guideline recommendations, which support the use of combined modalities in hospitalised people (limited to those with trauma or undergoing surgery) at risk of developing VTE. More studies on the role of combined modalities in VTE prevention are needed to provide evidence for specific patient groups and to increase our certainty in the evidence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005258-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005258-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005258-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005258-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005258-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005258-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005258-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005258-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD005258-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005258-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005258-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005258-abs-0002" lang="en"> <h3>Are inflatable sleeves and medication effective to prevent deep vein thrombosis and pulmonary embolism after surgery? </h3> <p><b>Key message</b> </p> <p>• The use of inflatable sleeves worn on the legs (intermittent pneumatic leg compression) plus medication may reduce the rate of new cases of blood clots in the lungs and legs compared to inflatable sleeves alone. </p> <p>• The use of inflatable sleeves plus medication compared to medication alone reduces the rate of new cases of blood clots in the legs and may reduce new blood clots in the lungs. </p> <p>• The addition of a medication to inflatable sleeves, may increase the risk of bleeding compared to inflatable sleeves alone.   </p> <p><b>Why is this question important?</b> </p> <p>Deep vein thrombosis (DVT) and pulmonary embolism are collectively known as venous thromboembolism, and occur when a blood clot develops inside the leg veins and travels to the lungs. They are possible complications of staying in hospital after surgery, trauma or other risk factors. These complications extend hospital stay and are associated with long‐term disability and death. Patients undergoing total hip or knee replacement (orthopaedic) surgery or surgery for colorectal cancer are at high risk of venous thromboembolism. Sluggish blood flow, increased blood clotting and blood vessel wall injury are factors that make it more likely that people will experience a blood clot. Treating more than one of these factors may improve prevention. Mechanical intermittent pneumatic leg compression involves wrapping the legs with inflatable sleeves or using foot pumps. These put gentle pressure on the legs and its veins, reducing sluggish blood flow, while medications such as aspirin and anticoagulants reduce blood clotting. These medications are known as pharmacological prophylaxis (drugs used to prevent blood clots). However, these medications can also increase the risk of bleeding.  We wanted to find out if combining compression and medication to stop blood clots was more effective than either compression or medication alone.  </p> <p><b>What did we find?</b> </p> <p>We searched for studies that compared combined compression and medication against either compression or medication alone. We found 34 studies with a total of 14,931 participants. The mean age of participants, where reported, was 62.7 years. Most participants had either a high‐risk procedure or condition (orthopaedic surgery in 14 studies and urology, cardiothoracic, neurosurgery, trauma, general surgery, gynaecology or other types of participants in the remaining studies). </p> <p>Compared to compression alone, compression plus medication was better by reducing the rate of new cases of pulmonary embolism (19 studies, 5462 participants). DVT was also reduced for compression combined with medication when compared with compression alone (18 studies, 5394 participants). The addition of a medication to compression, however, increased the risk of any bleeding compared to IPC alone, from 1% to 5.9%. Major bleeding followed a similar pattern, with an increase from 0.3% to 2.2%. Further analysis looking at different types of participants (orthopaedic and non‐orthopaedic participants) showed a similar risk for DVT. It was not possible to assess differences between subgroups for pulmonary embolism. </p> <p>Compared with medication alone, combined compression and medication was better by reducing pulmonary embolism (15 studies with 6737 participants). DVT was also reduced in the combined compression and medication group (17 studies with 6151 participants). No differences were observed in rates of bleeding (six studies with 1314 participants). Further analysis looking at different subgroups of participants did not show any overall difference in incidence of pulmonary embolism or DVT between orthopaedic and non‐orthopaedic participants. </p> <p><b>How certain are we in the evidence?</b> </p> <p>We found our confidence in the evidence ranged from high to very low. We had concerns on how the studies were carried out, because there were small numbers of clots overall and different definitions used for bleeding between the studies. </p> <p><b>How up to date is this evidence?</b> </p> <p>This review updates our previous evidence. The evidence is current to January 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005258-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005258-sec-0068"></div> <h3 class="title" id="CD005258-sec-0069">Implications for practice</h3> <section id="CD005258-sec-0069"> <p>Evidence suggests that combining intermittent pneumatic compression (IPC) with pharmacological prophylaxis compared with IPC, reduces the incidence of pulmonary embolism (PE) and deep vein thrombosis (DVT); both low‐certainty evidence. Combining IPC with pharmacological prophylaxis, compared with pharmacological prophylaxis alone also reduced the incidence of PE (low‐certainty evidence) and DVT (high‐certainty evidence). Very low‐certainty evidence suggests that the addition of pharmacological prophylaxis to IPC increased the risk of bleeding compared to IPC alone, a side effect not reported when adding IPC to pharmacological prophylaxis (very low‐certainty evidence), as expected for a physical method of thromboprophylaxis. We downgraded the certainty of the evidence due to risk of bias in study methodology, imprecision and indirectness, highlighting the need for further research. The results of the current review agree with guideline recommendations for hospitalised people at risk of developing venous thromboembolism (VTE).  </p> </section> <h3 class="title" id="CD005258-sec-0070">Implications for research</h3> <section id="CD005258-sec-0070"> <p>Most participants who received combined modalities in the studies reviewed were at high risk of developing VTE. Although the relative VTE reduction was large in this group, the same cannot be extrapolated for patients at moderate risk. Future studies should therefore address this question and also take into account cost‐effectiveness issues; looking at benefits in terms of reduced hospital stay, rehabilitation, mortality and long‐term complications, for example post‐thrombotic syndrome, which add to the burden of disability in the community in the long term. Future research using RCTs in other patient groups (such as patients with stroke or medical ICU patients) and confirmatory RCTs are warranted. Nevertheless, cost‐effectiveness for combined modalities has been demonstrated in certain high‐risk groups by the NICE guidelines (<a href="./references#CD005258-bbs2-0079" title="National Clinical Guideline Centre - Acute and chronic conditions.Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. nice.org.uk/guidance/cg92/ (accessed April 2016).">NICE 2009</a>), and also in orthopaedic patients undergoing lower limb arthroplasty (<a href="./references#CD005258-bbs2-0089" title="Torrejon TorresR , SaundersR , HoKM .A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia. Journal of Orthopaedic Surgery and Research2019;14(1):93.">Torrejon Torres 2019</a>). Cost‐effectiveness analysis should be performed in order to define the impact of this policy on health economics in both high‐risk and moderate‐risk patients. </p> <p>More studies on the role of combined modalities (as opposed to pharmacological prophylaxis alone) in orthopaedic and non‐orthopaedic patients are urgently needed. </p> <p>Future research should also aim to use standardised bleeding criteria such as those defined by the International Society on Thrombosis and Haemostasis (<a href="./references#CD005258-bbs2-0086" title="SchulmanS , AngeråsU , BergqvistD , ErikssonB , LassenMR , FisherW , on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. Journal of Thrombosis and Haemostasis2010;8(1):202-4.">Schulman 2010</a>). </p> <p>Further research should compare the efficacy of improved single modalities, including more effective schedule changes, with their combinations (<a href="./references#CD005258-bbs2-0066" title="ErikssonBI , BauerKA , LassenMR , TurpieAG , for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study.Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. New England Journal of Medicine2001;345(18):1298-304.">Eriksson 2001</a>; <a href="./references#CD005258-bbs2-0074" title="KakkosSK , GriffinM , GeroulakosG , NicolaidesAN .The efficacy of a new portable sequential compression device (SCD Express) in preventing venous stasis. Journal of Vascular Surgery2005;42(2):296-303.">Kakkos 2005a</a>; <a href="./references#CD005258-bbs2-0076" title="KingCS , HolleyAB , JacksonJL , ShorrAF , MooresLK .Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a meta-analysis. Chest2007;131(2):507-16.">King 2007</a>; <a href="./references#CD005258-bbs2-0067" title="ErikssonBI , BorrisLC , FriedmanRJ , HaasS , HuismanMV , KakkarAK , et al.Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. New England Journal of Medicine2008;358(26):2765-75.">Eriksson 2008</a>). Only two studies in the present review used a direct oral anticoagulant (<a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>). Further research on the effect of combined use of recently introduced, improved prophylactic modalities is justified. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005258-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005258-sec-0008"></div> <div class="table" id="CD005258-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Does combined intermittent pneumatic compression (IPC) plus pharmacological prophylaxis increase prevention of venous thromboembolism compared with IPC alone?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing surgery or at risk of developing VTE due to surgery, trauma or ICU stay </p> <p><b>Settings:</b> hospital  </p> <p><b>Intervention:</b> combined modalities ‐  IPC plus pharmacological prophylaxis </p> <p><b>Comparison:</b> IPC alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects <sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with IPC alone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with combined modalities</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of PE</b><sup>a</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> (4 to 12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.51</b> (0.29 to 0.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5462 (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of DVT</b><sup>c</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> (14 to 28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.51</b> (0.36 to 0.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5394 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of bleeding</b><sup>d</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 1000</b> (36 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 6.02</b> (3.88 to 9.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4634 (13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b><sup>f</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> (10 to 39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 5.77</b> (2.81 to 11.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4133 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval;<b>DVT:</b> deep vein thrombosis;<b>ICU:</b> intensive care unit; <b>IPC:</b> intermittent pneumatic compression; <b>OR:</b> odds ratio; <b>PE:</b> pulmonary embolism; <b>VTE:</b> venous thromboembolism </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.  </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Pulmonary embolism assessed by pulmonary angiography or scintigraphy, computed tomography (CT), angiography, or autopsy.<br/><sup>b</sup>Downgraded by two levels due to risk of bias concerns (high in one or more domains regarding all but one study) and due to imprecision as a result of a small number of overall events.<br/><sup>c</sup>Deep vein thrombosis assessed by ascending venography, I‐125 fibrinogen uptake test, and ultrasound scanning.<br/><sup>d</sup> Any type of bleeding as described by the study authors.<br/><sup>e</sup>Downgraded by three levels due to risk of bias concerns (high in one or more domains regarding all but one study), due to imprecision as a result of a small number of events overall, and indirectness because bleeding definitions were not uniform across the studies.<br/><sup>f</sup>Major bleeding as defined by the study authors, but usually located at the surgical site or in a critical organ or site, requiring intervention or transfusion of at least units of blood, or leading to death. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005258-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Does combined intermittent pneumatic compression (IPC) plus pharmacological prophylaxis increase prevention of venous thromboembolism compared with pharmacological prophylaxis alone?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing surgery or at risk of developing VTE because of surgery, trauma or ICU stay </p> <p><b>Settings:</b> hospital  </p> <p><b>Intervention:</b> combined modalities ‐ IPC plus pharmacological prophylaxis </p> <p><b>Comparison:</b> pharmacological prophylaxis alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects <sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with pharmacological prophylaxis alone</b> </p> <p><b> </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with combined modalities</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of PE</b><sup>a</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> (6 to 13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.46</b> (0.30 to 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6737 (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of DVT</b><sup>c</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> (21 to 67) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.38</b> (0.21 to 0.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6151 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of bleeding</b><sup>e</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> (43 to 98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.87</b> (0.56 to 1.35 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1314 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b><sup>g</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>13 per 1000</b> (4 to 44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.21</b> (0.35 to 4.18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>908 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very <b>low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval;<b>DVT:</b> deep vein thrombosis;<b>ICU:</b> intensive care unit; <b>IPC:</b> intermittent pneumatic compression; <b>OR:</b> odds ratio; <b>PE:</b> pulmonary embolism; <b>VTE:</b> venous thromboembolism </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Pulmonary embolism assessed by pulmonary angiography or scintigraphy, computed tomography (CT), angiography, single photon emission CT (SPECT) or autopsy.<br/><sup>b</sup>Downgraded by two levels due to risk of bias (which was high in one or more domains regarding all studies) and due to imprecision as a result of a small number of events overall.<br/><sup>c</sup>Deep vein thrombosis assessed predominantly by ascending venography, I‐125 fibrinogen uptake test, and ultrasound scanning.<br/><sup>d</sup>Downgraded by one level due to risk of bias (which was high in one or more domains regarding all but one study) and upgraded by one level because of a large magnitude of the effect.<br/><sup>e</sup>Any type of bleeding as described by the study authors.<br/><sup>f</sup>Downgraded by three levels due to risk of bias (which was high in one or more domains regarding all studies), due to imprecision as a result of a small number of events overall and a wide confidence interval, and indirectness because bleeding definitions were not uniform across the studies.<br/><sup>g</sup>Major bleeding as defined by the study authors, but usually located at the surgical site or in a critical organ or site, requiring intervention or transfusion of at least units of blood, or leading to death. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005258-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005258-sec-0009"></div> <p>It has been proposed that combined modalities are more effective than single modalities in preventing venous thromboembolism (VTE), defined as deep vein thrombosis (DVT) or pulmonary embolism (PE), or both. This is the second update of the review first published in 2008. </p> <section id="CD005258-sec-0010"> <h3 class="title" id="CD005258-sec-0010">Description of the condition</h3> <p>Deep vein thrombosis (DVT), that is, the development of thrombi (blood clots) inside the deep veins of the legs (in most instances), is a potentially fatal disease as it can be complicated by pulmonary embolism (PE), resulting from the movement of thrombi from the leg veins to the pulmonary artery or its branches. The incidence of venous thromboembolism (VTE), DVT, PE or both, is still high despite the use of contemporary prophylactic measures. VTE risk is increased by the presence of certain risk factors, including, age, malignancy, immobilisation, and the type of surgery. High‐risk patients include those undergoing total hip or knee replacement, or surgery for colorectal cancer (<a href="./references#CD005258-bbs2-0078" title="McLeodRS , GeertsWH , SnidermanKW , GreenwoodC , GregoireRC , TaylorBM , et al Canadian Colorectal Surgery DVT Prophylaxis Trial investigators.Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Annals of Surgery2001;233(3):438-44.">McLeod 2001</a>). Experts in the field have indicated that this and similar observations are the result of failed and also omitted prophylaxis (<a href="./references#CD005258-bbs2-0068" title="GoldhaberSZ .Prophylaxis of venous thrombosis. Current Treatment Options in Cardiovascular Medicine2001;3(3):225-35.">Goldhaber 2001</a>; <a href="./references#CD005258-bbs2-0084" title="PiazzaG , SeddighzadehA , GoldhaberSZ .Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest2007;132(2):554-61.">Piazza 2007</a>). The most recent guidelines recommend combined pharmacological and mechanical prophylaxis in high‐risk groups, in an effort to maximise thromboprophylaxis (<a href="./references#CD005258-bbs2-0061" title="Anderson DR,  Morgano GP,  Bennett C,  Dentali F,  Francis CW,  GarciaDA , et al.American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Advances2019;3(23):3898-944.">ASH 2019</a>; <a href="./references#CD005258-bbs2-0069" title="GouldMK , GarciaDA , WrenSM , KaranicolasPJ , ArcelusJI , HeitJA , et al.Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141:e227S-e277S.">Gould 2012</a>; <a href="./references#CD005258-bbs2-0081" title="NicolaidesAN , FareedJ , KakkarAK , ComerotaAJ , GoldhaberSZ , HullR , et al.Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). International Angiology2013;32:111-260.">Nicolaides 2013</a>). It is likely that mechanical methods increase the efficacy of thromboprophylaxis and reduce death and morbidity rates without increasing bleeding risk. </p> </section> <section id="CD005258-sec-0011"> <h3 class="title" id="CD005258-sec-0011">Description of the intervention</h3> <p>Intermittent pneumatic leg compression (IPC) involves wrapping the legs with inflatable sleeves, using commercially available devices. As a result of sleeve inflation, external pressure is exerted on the legs and its veins, resulting in an increase in blood flow and this reduction of blood stasis decreases the incidence of VTE. Pharmacological prophylaxis on the other hand is achieved by mostly small doses of anticoagulants given orally or subcutaneously; these also significantly reduce the incidence of VTE. Combined IPC and pharmacological prophylaxis in the form of dual modalities concurrently used for prevention of VTE may improve the efficacy of each method used alone. </p> </section> <section id="CD005258-sec-0012"> <h3 class="title" id="CD005258-sec-0012">How the intervention might work</h3> <p>Mechanical methods reduce VTE mainly by reducing venous stasis, while anticoagulants inhibit elements of the thrombosis cascade. Because single prophylactic modalities reduce but do not completely eliminate VTE, combined modalities are expected to reduce further the frequency of VTE because of their different mechanisms of action. </p> </section> <section id="CD005258-sec-0013"> <h3 class="title" id="CD005258-sec-0013">Why it is important to do this review</h3> <p>This is the second update of a Cochrane Review first published in 2008 (<a href="./references#CD005258-bbs2-0093" title="KakkosSK , CapriniJA , GeroulakosG , NicolaidesAN , StansbyG , ReddyDJ .Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD005258. [DOI: 10.1002/14651858.CD005258.pub2]">Kakkos 2008</a>). VTE is the single most common, preventable cause of postoperative death. Better use of preventive resources is expected to reduce VTE events and mortality. Use of combined modalities is suggested by current guidelines in high‐risk patients, however the evidence supporting these recommendations requires better attention (<a href="./references#CD005258-bbs2-0069" title="GouldMK , GarciaDA , WrenSM , KaranicolasPJ , ArcelusJI , HeitJA , et al.Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141:e227S-e277S.">Gould 2012</a>; <a href="./references#CD005258-bbs2-0081" title="NicolaidesAN , FareedJ , KakkarAK , ComerotaAJ , GoldhaberSZ , HullR , et al.Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). International Angiology2013;32:111-260.">Nicolaides 2013</a>). We performed this update to assess the breadth and strength of the best available evidence by pooling data from multiple studies to overcome the limitations of small and underpowered studies.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005258-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005258-sec-0014"></div> <p>The aim of this review was to assess the efficacy of combined intermittent pneumatic leg compression (IPC) and pharmacological prophylaxis compared to single modalities in preventing VTE. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005258-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005258-sec-0015"></div> <section id="CD005258-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005258-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and controlled clinical trials (CCTs).  We excluded studies with non‐standard designs, such as cross‐over trials and cluster‐randomised trials because they were deemed inappropriate in this context. </p> </section> <section id="CD005258-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included any type of hospitalised patient requiring prevention of venous thromboembolism (VTE) or at risk of developing VTE. We included participants undergoing surgery and trauma and intensive care unit (ICU) patients. </p> </section> <section id="CD005258-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies that assessed the combined use of IPC (including foot pumps and devices inflating calf sleeves) and pharmacological prophylaxis (including unfractionated heparin and low molecular weight heparin) compared with IPC or pharmacological prophylaxis alone. We excluded studies that used IPC for a short period of time (that is, intraoperatively). </p> </section> <section id="CD005258-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD005258-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005258-list-0001"> <li> <p>Incidence of PE, assessed by pulmonary angiography or scintigraphy, computed tomography (CT), angiography and autopsy for PE </p> </li> <li> <p>Incidence of DVT (symptomatic or asymptomatic), assessed by ascending venography, I‐125 fibrinogen uptake test and ultrasound scanning </p> </li> </ul> </p> </section> <section id="CD005258-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005258-list-0002"> <li> <p>Bleeding: considered as a safety outcome and including all types reported, that is, any type </p> </li> <li> <p>Major bleeding (as defined by the study authors, but usually located at the surgical site or in a critical organ or site, requiring intervention or transfusion of at least two units of blood, or leading to death), and fatal bleeding reported separately </p> </li> <li> <p>Fatal PE, assessed by autopsy</p> </li> <li> <p>Symptomatic DVT, assessed by ascending venography, I‐125 fibrinogen uptake test and ultrasound scanning </p> </li> </ul> </p> </section> </section> </section> <section id="CD005258-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005258-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for RCTs and CCTs without language, publication year or publication status restrictions. </p> <p> <ul id="CD005258-list-0003"> <li> <p>Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS‐Web searched on 18 January 2021) </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (CRSO 2020, Issue 12) </p> </li> <li> <p>MEDLINE (Ovid MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE) (searched from 3 May 2016 to 13 January 2021) </p> </li> <li> <p>Embase Ovid (searched from 3 May 2016 to 18 January 2021)</p> </li> <li> <p>CINAHL Ebsco (searched from 3 May 2016 to 18 January 2021)</p> </li> <li> <p>AMED Ovid (searched from 3 May 2016 to 18 January 2021)</p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for CENTRAL. Where appropriate, they were combined with adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and CCTs (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> chapter 4, <a href="./references#CD005258-bbs2-0077" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al.Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Lefebvre 2021</a>). Search strategies for major databases are provided in <a href="./appendices#CD005258-sec-0074">Appendix 1</a>. </p> <p>The Information Specialist searched these trials registries on 18 January 2021:</p> <p> <ul id="CD005258-list-0004"> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch" target="_blank">who.int/trialsearch</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD005258-sec-0025"> <h4 class="title">Searching other resources</h4> <p>The review authors searched the reference lists of relevant articles and also similar systematic reviews and meta‐analyses to identify additional studies.  We also carried out clinical trial database searches up to 12 July 2021. See <a href="./appendices#CD005258-sec-0075">Appendix 2</a>. </p> </section> </section> <section id="CD005258-sec-0026"> <h3 class="title" id="CD005258-sec-0026">Data collection and analysis</h3> <section id="CD005258-sec-0027"> <h4 class="title">Selection of studies</h4> <p>For this update, two review authors (SK and GK) independently selected studies for inclusion on the basis of the use of combined mechanical IPC and pharmacological modalities. We resolved any disagreements by discussion. </p> </section> <section id="CD005258-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>For this update, two review authors (SK and GK) independently extracted the data. We used a data extraction form to record the type of patient or surgical procedure, total number of participants in the study (including those randomised, excluded and also withdrawn), the interventions used, the number of participants who reached an endpoint (DVT or PE) and the methodology used to establish this. A third review author (JC) arbitrated any disagreements. </p> </section> <section id="CD005258-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For this update, we assessed the methodological quality of included studies using Cochrane's risk of bias tool (RoB 1). SK and GK independently performed the assessment according to <a href="./references#CD005258-bbs2-0072" title="HigginsJP , AltmanDG , Sterne JA (editors).Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from training.cochrane.org/handbook/archive/v5.1/2011.">Higgins 2011</a>. We assessed the following domains: selection bias (random sequence generation, allocation concealment), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), reporting bias (selective reporting) and other bias. We classified the domains as low risk, high risk, or unclear risk according to <a href="./references#CD005258-bbs2-0072" title="HigginsJP , AltmanDG , Sterne JA (editors).Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from training.cochrane.org/handbook/archive/v5.1/2011.">Higgins 2011</a>. We resolved any disagreements after discussion. </p> </section> <section id="CD005258-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We performed separate analyses for the interventions of IPC versus combined modalities, and pharmacological prophylaxis versus combined modalities for the outcomes of PE and DVT. We used odds ratios (ORs) with 95% confidence intervals (CIs) for the assessment of dichotomous outcomes.  None of our outcomes of interest were reported as continuous data. </p> </section> <section id="CD005258-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We excluded studies with non‐standard designs, such as cross‐over trials and cluster‐randomised trials. The individual participant was the unit of analysis. </p> </section> <section id="CD005258-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>In case of missing participants due to dropout, we used intention‐to‐treat analysis. Where necessary, we contacted study authors to request that they provided any missing information. </p> </section> <section id="CD005258-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity with the I<sup>2</sup> test (<a href="./references#CD005258-bbs2-0071" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG .Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>). We considered I<sup>2</sup> test levels exceeding 50% as substantial heterogeneity to justify the use of random‐effects model analysis (<a href="./references#CD005258-bbs2-0064" title="DeeksJJ , HigginsJP , Altman DG editor(s).Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Deeks 2021</a>). We also considered the magnitude and direction of effects and the strength of evidence for heterogeneity (e.g. P value from the Chi<sup>2</sup> test, or a CI for I<sup>2</sup> test). </p> </section> <section id="CD005258-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed publication bias with funnel plots when 10 or more studies were included in a comparison and contributed to the effect estimate; as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005258-bbs2-0083" title="PageMJ , HigginsJP , SterneJA .Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Page 2021</a>). Where the number of studies in each comparison was not greater than 10 the plots lack the power to distinguish chance from real asymmetry (<a href="./references#CD005258-bbs2-0065" title="EggerM , DaveySG , SchneiderM , MinderC .Bias in meta-analysis detected by a simple, graphical test. British Medical Journal (Clinical Research Ed.)1997;315(7109):629-34.">Egger 1997</a>). </p> </section> <section id="CD005258-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We used fixed‐effect models for each meta‐analysis to pool data, unless there was evidence of heterogeneity, in which case we used a random‐effects model to calculate the ORs and 95% CIs (see <a href="#CD005258-sec-0033">Assessment of heterogeneity</a>). We only undertook meta‐analyses when it was meaningful to do so. That is, if the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense. If meta‐analysis was not possible, we planned to report the results using a narrative synthesis. </p> </section> <section id="CD005258-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>To investigate heterogeneity, we performed subgroup analysis of the primary outcomes by: </p> <p> <ul id="CD005258-list-0005"> <li> <p>surgery type (orthopaedic surgery compared to non‐orthopaedic surgery or other conditions);</p> </li> <li> <p>type of IPC (foot IPC and other than foot IPC).</p> </li> </ul> </p> </section> <section id="CD005258-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analysis of the primary outcomes by excluding studies with a high risk for bias in any one or more domains, based on the RoB 1, and by excluding CCTs, in order to test the robustness of the evidence. We also planned to perform sensitivity analysis of the primary outcomes by excluding studies with medical patients. </p> </section> <section id="CD005258-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created summary of findings tables for the comparisons of 'IPC plus pharmacological prophylaxis versus IPC alone' (<a href="./full#CD005258-tbl-0001">summary of findings Table 1</a>) and 'IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone' (<a href="./full#CD005258-tbl-0002">summary of findings Table 2</a>). We used <a href="./references#CD005258-bbs2-0070" title="McMaster University (developed by Evidence Prime)GRADEpro GDT.Version accessed 12 October 2021. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a> software to present the main findings of the review. We included the outcomes PE, DVT, incidence of bleeding, and incidence of major bleeding in the summary of findings tables. We calculated assumed control intervention risks from the mean number of events in the control groups of the selected studies for each outcome. We used the system developed by the GRADE working group for grading the certainty of the evidence as high, moderate, low and very low, based on within‐study risk of bias, directness of evidence, heterogeneity, precision of effects estimates, and risk of publication bias (<a href="./references#CD005258-bbs2-0062" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al.Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490-4.">Atkins 2004</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005258-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005258-sec-0039"></div> <section id="CD005258-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD005258-sec-0041"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD005258-fig-0001">Figure 1</a>.  We identified 12 additional studies for this 2021 update (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). We also identified four new ongoing studies (<a href="./references#CD005258-bbs2-0056" title="ChiCTR1800014257.The strategies of risk-stratified prophylaxis of deep venous thrombosis after gynecologic pelvic surgery in patients at different levels of risk: a prospective multicenter randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800014257 (first received 1 February 2018). ">ChiCTR1800014257</a>; <a href="./references#CD005258-bbs2-0057" title="EUCTR2007-006206-24.A blind randomized trial to compare the efficacy of intermittent pneumatic compression (IPC) with and without early anticoagulant treatment for prevention of venous thromboembolism (VTE) in patients with acute primary intracerebral hemorrhage (ICH) including comparison of the American and European guideline recommendations. who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006206-24-FI (first received 14 November 2007). ">EUCTR2007‐006206‐24</a>; <a href="./references#CD005258-bbs2-0059" title="NCT02271399.Comparative study of prophylactic agent for venous thromboembolism after total knee arthroplasty. clinicaltrials.gov/show/NCT02271399 (first received 22 October 2014). ">NCT02271399</a>; <a href="./references#CD005258-bbs2-0060" title="NCT03559114.PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST). clinicaltrials.gov/ct2/show/NCT03559114 (first received 15 June 2018). ">NCT03559114 (PROTEST)</a>. We did not identify any new excluded studies. </p> <div class="figure" id="CD005258-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD005258-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD005258-sec-0042"> <h4 class="title">Included studies</h4> <p>For this update we included 12 additional studies (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>), making a total of 34 studies that met the inclusion criteria (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>; see <a href="#CD005258-fig-0001">Figure 1</a>). We identified one additional publication of the full report to a study that had presented interim results included in the last update (<a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>). The included studies investigated 14,931 participants. Five publications had three arms (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>), using IPC, pharmacological prophylaxis and both, respectively. </p> <p>Twenty‐five studies involving a total of 12,672 participants were RCTs (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). The remaining nine studies were CCTs, which were classified according to the draft guidelines of the Cochrane Non‐Randomised Studies Methods Group (<a href="./references#CD005258-bbs2-0082" title="Cochrane Non-Randomised Studies Methods Group.Draft chapters for the Guidelines on non-randomised studies in Cochrane reviews. cochrane.dk/nrsmg/guidelines.htm 2001 (accessed August 2007).">NRSMG</a>). These included five quasi‐randomised CCTs that involved a total of 1106 participants (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>), and four CCTs with concurrent controls that involved a total of 1153 participants (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>).  </p> <p>Fourteen included studies evaluated orthopaedic patients (<a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>); three evaluated urology patients (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>); two evaluated cardiothoracic patients (<a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>); one study evaluated neurosurgery patients (<a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>); one, trauma patients (<a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>); one, intensive care, mostly medical, patients (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>); and 12 studies evaluated general surgery, gynaecology and other types of patients (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). Some 1566 participants (10.5%) had a medical condition requiring ICU stay (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>), and the remaining 13,365 participants (89.5%) had trauma or underwent surgery. Participant weighted mean age (in 29 studies that reported age; 11,379 participants) was 62.7 years (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). </p> <p>Pharmacological prophylaxis included unfractionated heparin (UFH) (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a> <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>), low molecular weight heparin (LMWH) (<a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>), any heparin type (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>), fondaparinux (<a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>), LMWH or fondaparinux (<a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>), UFH or warfarin (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>), warfarin or aspirin (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>) and a direct oral anticoagulant/factor Xa inhibitor (<a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>). </p> <p>IPC types included foot pumps (<a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>), and inflating calf sleeve devices (<a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>), or thigh‐high sleeves (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). One additional study reported the use of sleeves that inflated the foot, calf and thigh (<a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). Ten studies did not report the exact IPC type (<a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>), while in two multi‐centre studies the investigators were allowed to use the device type of their choice (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>). </p> <p>Five publications had three arms (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>), using IPC, pharmacological prophylaxis and both, respectively. Of the remaining 29 publications, prophylactic methods in the control group included: IPC in 16 studies, either without aspirin (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>) or with aspirin (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>); and pharmacological prophylaxis in 13 studies (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). The intervention group in all studies used combined modalities and only two studies used aspirin (<a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). </p> <p>Ultrasound was the main diagnostic modality to diagnose DVT and was used by most studies (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). Where reported, PE was diagnosed mainly with scintigraphy scanning (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>) or single photon emission CT (SPECT) (<a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>), a pulmonary angiogram (<a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>); or a CT pulmonary angiogram (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). </p> <p>Two studies did not report on DVT rates (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>), and four studies did not report on PE rates (<a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). </p> <p>Nineteen studies reported on bleeding outcomes (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). Many studies provided no specific bleeding definitions (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). The remaining studies, which did provide bleeding definitions, did not use uniform criteria (<a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). </p> </section> <section id="CD005258-sec-0043"> <h4 class="title">Excluded studies</h4> <p>For this update, we did not assess any new studies as excluded. We excluded a total of 21 studies in previous versions (<a href="./references#CD005258-bbs2-0035" title="AilawadiM , Del PrioreG .A comparison of thromboembolic prophylaxis in gynecologic oncology patients. International Journal of Gynecological Cancer2001;11(5):354-8. ">Ailawadi 2001</a>; <a href="./references#CD005258-bbs2-0036" title="EskanderMB , LimbD , StoneMH , FurlongAJ , ShardlowD , SteadD , et al.Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures: a pilot study. International Orthopaedics1997;21(4):259-61. ">Eskander 1997</a>; <a href="./references#CD005258-bbs2-0037" title="FrimDM , Barker FG 2nd, PolettiCE , HamiltonAJ .Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery1992;30(6):830-2. ">Frim 1992</a>; <a href="./references#CD005258-bbs2-0038" title="GagnerM , SelzerF , BelleSH , BesslerM , CourcoulasAP , DakinGF , et al.Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. Surgery for Obesity and Related Diseases2012;8(6):663-70. ">Gagner 2012</a>; <a href="./references#CD005258-bbs2-0039" title="GelferY , TavorH , OronA , PeerA , HalperinN , RobinsonD .Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin. Journal of Arthroplasty2006;21(2):206-14. ">Gelfer 2006</a>; <a href="./references#CD005258-bbs2-0040" title="KamranSI , DowneyD , RuffRL .Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology1998;50(6):1683-8. ">Kamran 1998</a>; <a href="./references#CD005258-bbs2-0041" title="KiudelisM , GerbutaviciusR , GerbutavicieneR , GriniūteR , MickeviciusA , EndzinasZ , et al.A combinative effect of low-molecular-weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication. Medicina2010;46:18-23. ">Kiudelis 2010</a>; <a href="./references#CD005258-bbs2-0042" title="KumaranR , SokolovicM , AshameE , GeorgeEM , BernsteinL , GeorgeL .Prevention of venous thromboembolism in critically ill medical patients. Chest2008;134(4):36003s. ">Kumaran 2008</a>; <a href="./references#CD005258-bbs2-0043" title="LiebermanJR , HuoMM , HanwayJ , SalvatiEA , SculcoTP , SharrockNE .The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. Journal of Bone and Joint Surgery1994;76-A(3):341–8. ">Lieberman 1994</a>; <a href="./references#CD005258-bbs2-0044" title="MacdonaldRL , AmideiC , BaronJ , WeirB , BrownF , EricksonRK , et al.Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surgical Neurology2003;59(5):363-72; discussion 372-4. ">Macdonald 2003</a>; <a href="./references#CD005258-bbs2-0045" title="MehtaKV , LeeHC , LohJS .Mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong)2010;18(3):287-9. MehtaKV , LeeHC , LohJS .Reply to a letter to the Editor re: mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong)2011;19(2):260-2. ">Mehta 2010</a>; <a href="./references#CD005258-bbs2-0046" title="NathanSS , SimmonsKA , LinPP , HannLE , MorrisCD , AthanasianEA , et al.Proximal deep vein thrombosis after hip replacement for oncologic indications. Journal of Bone and Joint Surgery - American Volume2006;88(5):1066-70. ">Nathan 2006</a>; <a href="./references#CD005258-bbs2-0047" title="PatelAR , CristMK , NemitzJ , MayersonJL .Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients. Journal of Surgical Oncology2010;102:276–81. ">Patel 2010</a>; <a href="./references#CD005258-bbs2-0048" title="RobertsVC , CottonLT .Failure of low-dose heparin to improve efficacy of perioperative intermittent calf compression in preventing postoperative deep vein thrombosis. British Medical Journal1975;3(5981):458-60. ">Roberts 1975</a>; <a href="./references#CD005258-bbs2-0049" title="Spinal Cord Injury Thromboprophylaxis Investigators.Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. Journal of Trauma - Injury Infection and Critical Care2003;54(6):1116-24; discussion 1125-6. ">Spinal cord injury investigators</a>; <a href="./references#CD005258-bbs2-0050" title="StannardJP , Lopez-BenRR , VolgasDA , AndersonER , BusbeeM , KarrDK , et al.Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. Journal of Bone and Joint Surgery - American Volume2006;88(2):261-6. ">Stannard 2006</a>; <a href="./references#CD005258-bbs2-0051" title="TsutsumiK , UdagawaH , KajiyamaY , KinoshitaY , UenoM , NakamuraT , et al.Pulmonary thromboembolism after surgery for esophageal cancer: its features and prophylaxis. Surgery Today2000;30(5):416-20. ">Tsutsumi 2000</a>; <a href="./references#CD005258-bbs2-0052" title="WanB , Fu H-Y, Yin J-T, Ren G-Q.Low‑molecular‑weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients. Experimental and Therapeutic Medicine2015;10(6):2331-6. ">Wan 2015</a>; <a href="./references#CD005258-bbs2-0053" title="WestrichGH , SculcoTP .Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. Journal of Bone and Joint Surgery1996;78-A(6):826-34. ">Westrich 1996</a>; <a href="./references#CD005258-bbs2-0054" title="WhitworthJM , SchneiderKE , FrederickPJ , FinanMA , ReedE , FauciJM , et al.Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?International Journal of Gynecological Cancer2011;21(6):1131-4. ">Whitworth 2011</a>; <a href="./references#CD005258-bbs2-0055" title="WinemillerMH , Stolp-SmithKA , SilversteinMD , TherneauTM .Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. Journal of Spinal Cord Medicine1999;22(3):182-91. ">Winemiller 1999</a>). Exclusions were because five studies' use of combined modalities was not concurrent or a different type of pharmacological prophylaxis was given in the two study groups (<a href="./references#CD005258-bbs2-0036" title="EskanderMB , LimbD , StoneMH , FurlongAJ , ShardlowD , SteadD , et al.Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures: a pilot study. International Orthopaedics1997;21(4):259-61. ">Eskander 1997</a>; <a href="./references#CD005258-bbs2-0039" title="GelferY , TavorH , OronA , PeerA , HalperinN , RobinsonD .Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin. Journal of Arthroplasty2006;21(2):206-14. ">Gelfer 2006</a>; <a href="./references#CD005258-bbs2-0044" title="MacdonaldRL , AmideiC , BaronJ , WeirB , BrownF , EricksonRK , et al.Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surgical Neurology2003;59(5):363-72; discussion 372-4. ">Macdonald 2003</a>; <a href="./references#CD005258-bbs2-0049" title="Spinal Cord Injury Thromboprophylaxis Investigators.Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. Journal of Trauma - Injury Infection and Critical Care2003;54(6):1116-24; discussion 1125-6. ">Spinal cord injury investigators</a>; <a href="./references#CD005258-bbs2-0050" title="StannardJP , Lopez-BenRR , VolgasDA , AndersonER , BusbeeM , KarrDK , et al.Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. Journal of Bone and Joint Surgery - American Volume2006;88(2):261-6. ">Stannard 2006</a>); in two studies IPC use was limited to intraoperative use (<a href="./references#CD005258-bbs2-0041" title="KiudelisM , GerbutaviciusR , GerbutavicieneR , GriniūteR , MickeviciusA , EndzinasZ , et al.A combinative effect of low-molecular-weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication. Medicina2010;46:18-23. ">Kiudelis 2010</a>; <a href="./references#CD005258-bbs2-0048" title="RobertsVC , CottonLT .Failure of low-dose heparin to improve efficacy of perioperative intermittent calf compression in preventing postoperative deep vein thrombosis. British Medical Journal1975;3(5981):458-60. ">Roberts 1975</a>); three studies were controlled before and after studies (<a href="./references#CD005258-bbs2-0037" title="FrimDM , Barker FG 2nd, PolettiCE , HamiltonAJ .Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery1992;30(6):830-2. ">Frim 1992</a>; <a href="./references#CD005258-bbs2-0040" title="KamranSI , DowneyD , RuffRL .Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology1998;50(6):1683-8. ">Kamran 1998</a>; <a href="./references#CD005258-bbs2-0051" title="TsutsumiK , UdagawaH , KajiyamaY , KinoshitaY , UenoM , NakamuraT , et al.Pulmonary thromboembolism after surgery for esophageal cancer: its features and prophylaxis. Surgery Today2000;30(5):416-20. ">Tsutsumi 2000</a>); six studies were retrospective case‐control studies (<a href="./references#CD005258-bbs2-0035" title="AilawadiM , Del PrioreG .A comparison of thromboembolic prophylaxis in gynecologic oncology patients. International Journal of Gynecological Cancer2001;11(5):354-8. ">Ailawadi 2001</a>; <a href="./references#CD005258-bbs2-0046" title="NathanSS , SimmonsKA , LinPP , HannLE , MorrisCD , AthanasianEA , et al.Proximal deep vein thrombosis after hip replacement for oncologic indications. Journal of Bone and Joint Surgery - American Volume2006;88(5):1066-70. ">Nathan 2006</a>; <a href="./references#CD005258-bbs2-0047" title="PatelAR , CristMK , NemitzJ , MayersonJL .Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients. Journal of Surgical Oncology2010;102:276–81. ">Patel 2010</a>; <a href="./references#CD005258-bbs2-0052" title="WanB , Fu H-Y, Yin J-T, Ren G-Q.Low‑molecular‑weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients. Experimental and Therapeutic Medicine2015;10(6):2331-6. ">Wan 2015</a>; <a href="./references#CD005258-bbs2-0054" title="WhitworthJM , SchneiderKE , FrederickPJ , FinanMA , ReedE , FauciJM , et al.Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?International Journal of Gynecological Cancer2011;21(6):1131-4. ">Whitworth 2011</a>; <a href="./references#CD005258-bbs2-0055" title="WinemillerMH , Stolp-SmithKA , SilversteinMD , TherneauTM .Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. Journal of Spinal Cord Medicine1999;22(3):182-91. ">Winemiller 1999</a>); one was a registry study (<a href="./references#CD005258-bbs2-0038" title="GagnerM , SelzerF , BelleSH , BesslerM , CourcoulasAP , DakinGF , et al.Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. Surgery for Obesity and Related Diseases2012;8(6):663-70. ">Gagner 2012</a>); in another the single modalities group used either heparin or IPC (<a href="./references#CD005258-bbs2-0042" title="KumaranR , SokolovicM , AshameE , GeorgeEM , BernsteinL , GeorgeL .Prevention of venous thromboembolism in critically ill medical patients. Chest2008;134(4):36003s. ">Kumaran 2008</a>); two studies used aspirin for thromboprophylaxis (<a href="./references#CD005258-bbs2-0043" title="LiebermanJR , HuoMM , HanwayJ , SalvatiEA , SculcoTP , SharrockNE .The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. Journal of Bone and Joint Surgery1994;76-A(3):341–8. ">Lieberman 1994</a>; <a href="./references#CD005258-bbs2-0053" title="WestrichGH , SculcoTP .Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. Journal of Bone and Joint Surgery1996;78-A(6):826-34. ">Westrich 1996</a>), and one study provided only aggregated VTE rates and not separate DVT and PE rates (<a href="./references#CD005258-bbs2-0045" title="MehtaKV , LeeHC , LohJS .Mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong)2010;18(3):287-9. MehtaKV , LeeHC , LohJS .Reply to a letter to the Editor re: mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong)2011;19(2):260-2. ">Mehta 2010</a>). </p> </section> <section id="CD005258-sec-0044"> <h4 class="title">Ongoing studies</h4> <p>For this update, we identified four additional studies as ongoing (<a href="./references#CD005258-bbs2-0056" title="ChiCTR1800014257.The strategies of risk-stratified prophylaxis of deep venous thrombosis after gynecologic pelvic surgery in patients at different levels of risk: a prospective multicenter randomized controlled trial. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800014257 (first received 1 February 2018). ">ChiCTR1800014257</a>; <a href="./references#CD005258-bbs2-0057" title="EUCTR2007-006206-24.A blind randomized trial to compare the efficacy of intermittent pneumatic compression (IPC) with and without early anticoagulant treatment for prevention of venous thromboembolism (VTE) in patients with acute primary intracerebral hemorrhage (ICH) including comparison of the American and European guideline recommendations. who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006206-24-FI (first received 14 November 2007). ">EUCTR2007‐006206‐24</a>; <a href="./references#CD005258-bbs2-0059" title="NCT02271399.Comparative study of prophylactic agent for venous thromboembolism after total knee arthroplasty. clinicaltrials.gov/show/NCT02271399 (first received 22 October 2014). ">NCT02271399</a>; <a href="./references#CD005258-bbs2-0060" title="NCT03559114.PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST). clinicaltrials.gov/ct2/show/NCT03559114 (first received 15 June 2018). ">NCT03559114 (PROTEST)</a>), in addition to <a href="./references#CD005258-bbs2-0058" title="NCT00740987.Efficacy of the association mechanical prophylaxis plus anticoagulant prophylaxis on venous thromboembolism incidence in intensive care unit (ICU). clinicaltrials.gov/ct2/show/NCT00740987 (first received 25 August 2008). ">NCT00740987 (CIREA 2)</a>. See <a href="./references#CD005258-sec-0092" title="">Characteristics of ongoing studies</a>. </p> </section> </section> <section id="CD005258-sec-0045"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD005258-fig-0002">Figure 2</a> and <a href="#CD005258-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD005258-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD005258-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD005258-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD005258-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>We judged the overall risk of bias as mostly unclear or high due to concerns with selection bias, performance bias and detection bias. </p> <section id="CD005258-sec-0046"> <h4 class="title">Allocation</h4> <p>The randomisation methods were unclear in 12 of the 25 RCTs (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). Thirteen studies were at low risk of bias as they provided sufficient information using random tables (<a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>), a centralised computer‐generated schedule (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>), central randomisations without further details (<a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>), and sealed envelopes (<a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). As a result, the quality of RCTs was often poor regarding selection bias, which was generally at high risk. By definition, all quasi‐randomised trials and CCTs had a high risk for random sequence generation and therefore selection bias (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>). </p> <p>A high risk for allocation concealment was evident in 11 studies (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>). We deemed two studies with adequate randomisation methods to be at high risk for allocation concealment (<a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>). Only eight studies had a low risk for allocation bias (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>). In the remaining studies, the risk of selection bias due to allocation concealment was unclear (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). </p> </section> <section id="CD005258-sec-0047"> <h4 class="title">Blinding</h4> <p>A high risk of performance bias was evident in all studies except two RCTs, which were double‐blinded and so at low risk (<a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). We judged the remaining studies as being at high risk because of the lack of use of a placebo medication or device. Six studies reported blinding of outcome assessment of all outcomes so these were at low risk of detection bias (<a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). This was not the case in nine studies judged to be at high risk (<a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>), while in the remaining studies there was unclear evidence of detection bias. This lack of blinding may have affected the detection of DVT or PE and potentially increase the heterogeneity of the results. </p> </section> <section id="CD005258-sec-0048"> <h4 class="title">Incomplete outcome data</h4> <p>A total of 428 participants (2.9%) were excluded and a total of 88 participants (0.59%) were lost to follow‐up. Four studies reported some attrition but were judged to be at low risk of bias as the proportion of participants lost to follow‐up were unlikely to impact the results (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). One study excluded eight participants due to non‐compliance, confinement to bed for more than one week, premature transfer to a different institution, or re‐operation or discharge from hospital without ultrasonography (<a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>). We judged this unlikely to impact the results so deemed it at low risk of attrition bias. Another study excluded 11 participants because of a protocol violation (discharged before the ultrasound (6 participants)), or because they did not receive the correct study medication (5 participants); <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>). This study also reported a 26.5% loss to follow‐up, which was 0.59% of the total number of participants in this systematic review; short‐term data were provided but we judged this to be at high risk of bias (<a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>). A third study excluded 24 participants because inclusion or exclusion criteria were not met, informed consent was withdrawn, adverse events occurred, or for other reasons not stated so we judged this to be at high risk (<a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>). We deemed a high risk of bias present in a total of seven studies as we judged missing data or exclusions sufficient to impact the results (<a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>). The remaining studies were at low risk of bias (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). </p> </section> <section id="CD005258-sec-0049"> <h4 class="title">Selective reporting</h4> <p>We identified selective reporting in only one case where symptomatic DVT was not reported, so we judged this study to be at high risk of reporting bias (<a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>). All the other studies were at low risk as expected results were provided. </p> </section> <section id="CD005258-sec-0050"> <h4 class="title">Other potential sources of bias</h4> <p>We considered two studies as being at high risk for other sources of bias, because they were prematurely stopped (<a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>). Six studies were at unclear risk because of a lack of baseline characteristic details (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>). All the remaining studies were at low risk of other bias. </p> </section> </section> <section id="CD005258-sec-0051"> <h3 class="title" id="CD005258-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD005258-tbl-0001"><b>Summary of findings 1</b> IPC plus pharmacological prophylaxis versus IPC alone</a>; <a href="./full#CD005258-tbl-0002"><b>Summary of findings 2</b> IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</a> </p> <section id="CD005258-sec-0052"> <h4 class="title">Intermittent pneumatic leg compression (IPC) plus pharmacological prophylaxis versus IPC alone </h4> <p>See <a href="./full#CD005258-tbl-0001">summary of findings Table 1</a>.  </p> <p>Nineteen of the included studies evaluated the role of combined modalities on the incidence of symptomatic PE (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of PE was 0.65% (19/2932) in the combined group compared to 1.34% (34/2530) in the IPC‐alone group, showing a benefit for combined modalities (OR 0.51, 95% CI 0.29 to 0.91; 19 studies, 5462 participants; P = 0.02; low‐certainty evidence; <a href="./references#CD005258-fig-0004" title="">Analysis 1.1</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to low for risk of bias, and imprecision as a result of a small number of events. We carried out subgroup analysis by orthopaedic and non‐orthopaedic patient groups for PE incidence.  As no PE events were reported in the orthopaedic subgroup we were unable to test for differences (<a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>; <a href="./references#CD005258-fig-0004" title="">Analysis 1.1</a>). </p> <p>Fatal PE was not reported.</p> <p>We carried out subgroup analysis by foot IPC versus other IPC on incidence of PE. As no PE events were reported in the foot IPC subgroup we were unable to test for differences (<a href="./references#CD005258-fig-0005" title="">Analysis 1.2</a>). </p> <p>Eighteen studies investigated the role of combined modalities on the incidence of DVT (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of DVT was 2.03% (59/2900) in the combined group compared to 3.81% (95/2494) in the IPC group, showing a reduced incidence of DVT in favour of the combined modalities group (OR 0.51, 95% CI 0.36 to 0.72; 18 studies, 5394 participants; P = 0.0001; low‐certainty evidence; <a href="./references#CD005258-fig-0006" title="">Analysis 1.3</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to low for risk of bias, and imprecision as a result of a small number of events.  </p> <p>No difference was detected between the orthopaedic and non‐orthopaedic subgroups for DVT incidence (test for subgroup differences P = 0.19;  <a href="./references#CD005258-fig-0006" title="">Analysis 1.3</a>). </p> <p>Ten studies reported on the occurrence of symptomatic DVT (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of symptomatic DVT was 0.53% (12/2245) in the combined modalities group compared to 0.70% (13/1844) in the IPC control group, showing no clear evidence of a difference between the groups (OR 0.48, 95% CI 0.21 to 1.10; 10 studies, 4089 participants; P = 0.08; <a href="./references#CD005258-fig-0007" title="">Analysis 1.4</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of symptomatic DVT (test for subgroup differences P = 0.47; <a href="./references#CD005258-fig-0007" title="">Analysis 1.4</a>). </p> <p>One study investigated the role of combined modalities on the incidence of DVT using a foot IPC (<a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>), but because of a lack of events we could not calculate a risk estimate. Seventeen studies investigated the role of combined modalities on the incidence of DVT using IPC other than a foot IPC (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0013" title="KurtogluM , AksoyM , GencFA , BaktirogluS .The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology2003;18(3):148. YanarH , KurtogluM , TavilogluK , GulogluR , ErtekinC .Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery2007;33 Suppl II:79-80. ">Kurtoglu 2003</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0023" title="SieberPR , RommelFM , AgustaVE , BreslinJA , HarpsterLE , HuffnagleHW , et al .Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?Journal of Urology1997;158(3 Pt 1):869-71. ">Sieber 1997</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of DVT was 2.03% (59/2901) in the combined group compared to 3.81% (95/2494) in the IPC group, showing a reduced incidence of DVT in favour of the combined modalities group (OR 0.51, 95% CI 0.36 to 0.72; 17 studies, 5345 participants; P = 0.0001; <a href="./references#CD005258-fig-0008" title="">Analysis 1.5</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>Thirteen studies reported on the incidence of bleeding in the combined modalities and IPC groups (<a href="./references#CD005258-bbs2-0002" title="BiggSW , CatalonaWJ .Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology1992;39(4):309-13. ">Bigg 1992</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0027" title="TsutsumiS , YajimaR , TabeY , TakaakiT , FujiiF , MoritaH , et al.The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology2012;59(120):2477-9. ">Tsutsumi 2012</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of bleeding was 5.88% (137/2330) in the combined group compared to 0.95% (22/2304) in the IPC group, showing an increase in bleeding in the combined group (OR 6.02, 95% CI 3.88 to 9.35; 13 studies, 4634 participants; P &lt; 0.00001; very low‐certainty evidence; <a href="./references#CD005258-fig-0009" title="">Analysis 1.6</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to very low due to risk of bias, imprecision as a result of a small number of events, and indirectness. </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of bleeding (test for subgroup difference P = 0.22; <a href="./references#CD005258-fig-0009" title="">Analysis 1.6</a>). </p> <p>Major bleeding followed a similar pattern, with an incidence of 2.21% (46/2079) in the combined group compared to 0.34% (7/2054) in the IPC group (OR 5.77, 95% CI 2.81 to 11.83; 12 studies, 4133 participants; P &lt; 0.00001; very low‐certainty evidence; <a href="./references#CD005258-fig-0010" title="">Analysis 1.7</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to very low for risk of bias, imprecision as a result of a small number of events, and indirectness.  </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of major bleeding (test for subgroup difference P = 0.74;  <a href="./references#CD005258-fig-0010" title="">Analysis 1.7</a>). </p> <p>Fatal bleeding was not reported during the intervention period.</p> <p>No publication bias was indicated by investigating comparisons with funnel plots.</p> </section> <section id="CD005258-sec-0053"> <h4 class="title">Intermittent pneumatic leg compression (IPC) plus pharmacological prophylaxis versus pharmacological prophylaxis alone </h4> <p>See <a href="./full#CD005258-tbl-0002">summary of findings Table 2</a>.  </p> <p>Fifteen studies evaluated the role of combined modalities compared to pharmacological prophylaxis alone on the incidence of mainly symptomatic PE (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>). The incidence of PE was 0.91% (31/3419) in the combined group compared to 1.84% (61/3318) in the pharmacological prophylaxis control group showing a reduction in PE in favour of the combined modalities group (OR 0.46, 95% CI 0.30 to 0.71; 15 studies, 6737 participants; P = 0.0005; low‐certainty evidence; <a href="./references#CD005258-fig-0011" title="">Analysis 2.1</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to low for risk of bias, and due to imprecision as a result of a small number of events. </p> <p>No difference was detected between the orthopaedic and non‐orthopaedic subgroups for PE incidence (test for subgroup differences P = 0.82; <a href="./references#CD005258-fig-0011" title="">Analysis 2.1</a>). </p> <p>Two published studies reported fatal PE (<a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>). <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a> reported three cases of fatal PE, exclusively in the pharmacological prophylaxis‐alone group. <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a> did not provide the exact number of deaths or the treatment group they occurred in. The authors of a third study provided unpublished results; a single fatal PE occurred in the pharmacological prophylaxis‐alone group (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>). </p> <p>We carried out subgroup analysis by foot IPC versus other IPC on incidence of PE. This showed no difference between the two subgroups (test for subgroup differences P = 0.82; <a href="./references#CD005258-fig-0012" title="">Analysis 2.2</a>). </p> <p>Seventeen studies investigated the role of combined modalities on the incidence of DVT (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). The incidence of DVT was 5.48% (167/3046) in the combined group compared to 9.28% (288/3105) in the pharmacological prophylaxis control group showing a reduction in DVT in favour of the combined modalities group (OR 0.38, 95% CI 0.21 to 0.70; 17 studies, 6151 participants; P = 0.002; high‐certainty evidence; <a href="./references#CD005258-fig-0013" title="">Analysis 2.3</a>). Results demonstrated substantial heterogeneity so we used a random‐effects model (I<sup>2</sup> = 78%). The certainty of the evidence was high (downgraded by one level due to risk of bias and upgraded by one level because of a large magnitude of effect (&lt; 0.50 and &gt; 0.2)). </p> <p>No difference was detected between the orthopaedic and non‐orthopaedic subgroups for DVT incidence (test for subgroup differences P = 0.69; <a href="./references#CD005258-fig-0013" title="">Analysis 2.3</a>). </p> <p>Seven studies reported on the occurrence of symptomatic DVT (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>). The incidence of symptomatic DVT was 0.59% (9/1515) in the combined group compared to 0.73% (11/1517) in the pharmacological prophylaxis control group, showing no clear difference between the combined and single groups (OR 0.83, 95% CI 0.34 to 2.01; 7 studies, 3032 participants; P = 0.67; <a href="./references#CD005258-fig-0014" title="">Analysis 2.4</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%).  </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of symptomatic DVT (test for subgroup differences P = 0.20; <a href="./references#CD005258-fig-0014" title="">Analysis 2.4</a>). </p> <p>Four studies investigated the role of combined modalities on the incidence of DVT using a foot IPC (<a href="./references#CD005258-bbs2-0004" title="BradleyJG , KrugenerGH , JagerHJ .The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty1993;8(1):57-61. ">Bradley 1993</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>). The incidence of DVT was 13.07% (20/153) in the combined group compared to 16.37% (28/171) in the pharmacological prophylaxis‐alone control group showing no clear difference between the combined and single groups (OR 0.40, 95% CI 0.05 to 3.47; 4 studies, 324 participants; P = 0.41; <a href="./references#CD005258-fig-0015" title="">Analysis 2.5</a>). Results demonstrated substantial heterogeneity so we used a random‐effects model (I<sup>2</sup> = 81%). </p> <p>Twelve studies investigated the role of combined modalities on the incidence of DVT using IPC other than a foot IPC (<a href="./references#CD005258-bbs2-0003" title="BorowM , GoldsonHJ .Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon1983;49(11):599-605. ">Borow 1983</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). The incidence of DVT was 2.73% (52/1902) in the combined group compared to 9.11% (175/1922) in the pharmacological prophylaxis‐alone group, showing a reduced incidence of DVT in favour of the combined modalities group (OR 0.31, 95% CI 0.17 to 0.54; 12 studies, 3824 participants; P &lt; 0.0001; <a href="./references#CD005258-fig-0015" title="">Analysis 2.5</a>). The results demonstrated substantial heterogeneity and we used a random‐effects model (I<sup>2</sup> = 50%). The test for subgroup differences did not detect any clear difference between the foot IPC or IPC other than foot subgroups (P = 0.81). </p> <p>Six studies reported on the incidence of bleeding in the combined and pharmacological prophylaxis groups (<a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0016" title="LobastovK , SautinaE , AlenchevaE , BargandzhiyaA , SchastlivtsevI , BarinovV , et al.Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Annals of Surgery2021;274(1):63–9. [DOI: 10.1097/SLA.0000000000004556]">Lobastov 2021</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0022" title="CHICTR-IPR-15007324.The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007324 (first received 30 October 2015). SangCQ , ZhaoN , ZhangJ , WangSZ , GuoSL , LiSH , et al.Different combination strategies for prophylaxis of venous thromboembolism in patients: a prospective multicenter randomized controlled study. Scientific Reports2018;8(1):8277. [DOI: 10.1038/s41598-018-25274-2]">Sang 2018</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>). These studies showed no clear difference in bleeding rates between the combined group (43/656, 6.55%) and the pharmacological prophylaxis group (49/658, 7.45%; OR 0.87, 95% CI 0.56 to 1.35; 6 studies, 1314 participants; P = 0.53; very low‐certainty evidence; <a href="./references#CD005258-fig-0016" title="">Analysis 2.6</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to very low for risk of bias, indirectness and imprecision. </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of bleeding (test for subgroup difference P = 0.58; <a href="./references#CD005258-fig-0016" title="">Analysis 2.6</a>). </p> <p>There was also no clear difference in major bleeding rates between the combined group (6/452, 1.33%) and the pharmacological prophylaxis group (5/456, 1.10%; OR 1.21, 95% CI 0.35 to 4.18; 5 studies, 908 participants; P = 0.76; very low‐certainty evidence; <a href="./references#CD005258-fig-0017" title="">Analysis 2.7</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence to very low for risk of bias, indirectness and imprecision.  </p> <p>We did not detect a difference between the orthopaedic and non‐orthopaedic subgroups in incidence of major bleeding (test for subgroup difference P = 0.82; <a href="./references#CD005258-fig-0017" title="">Analysis 2.7</a>). </p> <p>Fatal bleeding during the intervention period was not reported.</p> <p>No publication bias was indicated by investigating comparisons with funnel plots.</p> </section> <section id="CD005258-sec-0054"> <h4 class="title">IPC plus pharmacological prophylaxis versus IPC plus aspirin</h4> <p>Three studies evaluated the role of combined IPC plus pharmacological prophylaxis versus IPC plus aspirin on the incidence of symptomatic PE (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). The studies showed a similar frequency of PE in the IPC plus pharmacological prophylaxis treatment groups (0/337, 0%) compared to the IPC plus aspirin control (2/268, 0.75%; OR 0.33, 95% CI 0.03 to 3.19; 3 studies, 605 participants; P = 0.34; <a href="./references#CD005258-fig-0018" title="">Analysis 3.1</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>Fatal PE was not reported.</p> <p>The same studies investigated the role of combined modalities compared to IPC plus aspirin on the incidence of DVT. The studies showed a similar frequency in DVT in the IPC plus pharmacological prophylaxis treatment groups (30/337, 8.9%) compared to the IPC plus aspirin control (32/268, 11.9%; OR 0.83, 95% CI 0.48 to 1.42; 3 studies, 605 participants; P = 0.49; <a href="./references#CD005258-fig-0019" title="">Analysis 3.2</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>One study reported on the occurrence of symptomatic DVT (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>), but because of the lack of events, we could not calculate a risk estimate (<a href="./references#CD005258-fig-0020" title="">Analysis 3.3</a>). </p> <p>The three studies in this comparison all included orthopaedic participants only and therefore subgroup analyses between orthopaedic and non‐orthopaedic groups were not possible (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). No foot IPC was used in this comparison and therefore subgroup analysis was not possible.  </p> <p>Three studies evaluated the role of combined IPC plus pharmacological prophylaxis versus IPC plus aspirin on the incidence of bleeding (<a href="./references#CD005258-bbs2-0029" title="WestrichGH , RanaAJ , TerryMA , TaverasNA , KapoorK , HelfetDL .Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma2005;19(4):234-40. ">Westrich 2005</a>; <a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). The studies showed a similar frequency in bleeding in the IPC plus pharmacological prophylaxis treatment groups (4/341, 1.2%) compared to the IPC plus aspirin control (2/275, 0.7%) (OR 1.23, 95% CI 0.27 to 5.53; 3 studies, 616 participants; P = 0.79; <a href="./references#CD005258-fig-0021" title="">Analysis 3.4</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>These studies also showed a similar frequency in major bleeding in the IPC plus pharmacological prophylaxis treatment groups (2/341, 0.6%) compared to the IPC plus aspirin control (2/275, 0.7%; OR 0.80, 95% CI 0.15 to 4.17; 3 studies, 616 participants; <a href="./references#CD005258-fig-0022" title="">Analysis 3.5</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>Fatal bleeding during the intervention period was not reported.</p> </section> <section id="CD005258-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analysis of the primary outcomes by excluding studies at a high risk of bias, by excluding CCTs, and by excluding studies when substantial heterogeneity was present, in order to test the robustness of the evidence. </p> <section id="CD005258-sec-0056"> <h5 class="title">Exclusion of studies with high risk of bias</h5> <p>Assessing the included studies for risk of bias showed a high number of studies at high risk for performance bias and at unclear risk for selection and detection bias. See <a href="#CD005258-fig-0002">Figure 2</a> and <a href="#CD005258-fig-0003">Figure 3</a>. We were unable to exclude studies at overall high risk because this included almost all studies, and did not leave enough studies within comparisons for meta‐analyses. Therefore, we did not perform sensitivity analysis for studies at high risk of bias. </p> </section> <section id="CD005258-sec-0057"> <h5 class="title">Exclusion of controlled clinical studies</h5> <section id="CD005258-sec-0058"> <h6 class="title">IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only</h6> <p>Exclusion of CCTs from the analysis did not change the overall effect on either PE or DVT. Thirteen RCTs evaluated the role of combined modalities on the incidence of mostly symptomatic PE (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). The incidence of PE in the combined group was 0.58% (12/2083), compared to 1.2% (25/2076) in the IPC control group, favouring combined modalities (OR 0.54, 95% CI 0.28 to 1.07; 13 RCTs, 4159 participants; P = 0.08; <a href="./references#CD005258-fig-0023" title="">Analysis 4.1</a>). Results demonstrated no substantial heterogeneity (I<sup>2</sup> = 20%). </p> <p>The same RCTs evaluated the role of combined modalities on the incidence of DVT (<a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0007" title="DongJ , WangJ , FengY , QiLP , FangH , WangGD , et al.Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer. Journal of Thoracic Disease2018;10(3):1850-6. [DOI: 10.21037/jtd.2018.03.13]">Dong 2018</a>; <a href="./references#CD005258-bbs2-0010" title="HataT , YasuiM , IkedaM , MiyakeM , IdeY , OkuyamaM , et al.Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Annals of Gastroenterological Surgery2019;3(5):568-75. ">Hata 2019</a>; <a href="./references#CD005258-bbs2-0011" title="JungYJ , SeoHS , ParkCH , JeonHM , KimJI , YimHW , et al.Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial. JAMA Surgery2018;153(10):939-46. [DOI: 10.1001/jamasurg.2018.2081]JungYJ , SongKY , SeoHS , ParkCH .Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: prospective randomized controlled trial. Journal of Clinical Oncology2017;35(4 Suppl):7. SongKY , YooHM , KimEY , KimJI , YimHW , JeonHM , et al.Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology2014;21(13):4232-8. ">Jung 2018</a>; <a href="./references#CD005258-bbs2-0012" title="KamachiH , HommaS , KawamuraH , YoshidaT , OhnoY , IchikawaN , et al.Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4(5):804-10. [DOI: 10.1002/bjs5.50323]">Kamachi 2020</a>; <a href="./references#CD005258-bbs2-0017" title="NakagawaK , WatanabeJ , OtaM , SuwaY , SuzukiS , SuwaH , et al.Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surgery Today2020;50(1):68-75. [DOI: 10.1007/s00595-019-01859-w]">Nakagawa 2020</a>; <a href="./references#CD005258-bbs2-0018" title="ObitsuT , TanakaN , OyamaA , UenoT , SaitoM , YamaguchiT , et al, Tohoku Surgical Clinical Research Promotion Organization Study Group.Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial. Journal of the American College of Surgeons2020;231(5):501-10. ">Obitsu 2020</a>; <a href="./references#CD005258-bbs2-0019" title="PatelH , FaisalF , TrockBB , JoiceG , SchwenZ , PierorazioP , et al.Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial. European Urology2020;78(3):360-8. ">Patel 2020</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0028" title="Del PrioreG , HerzogTJ , BauerKA , CapriniJA , CompP , GentM , et al.Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology2006;101:S21. TurpieAG , BauerKA , CapriniJA , CompPC , GentM , MuntzJE , on behalf of the APOLLO Investigators.Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. Journal of Thrombosis and Haemostasis2007;5(9):1854-61. TurpieAG , BauerKA , CapriniJA , CompPP , GentM , MuntzJE .Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood2005;106(11):Abstract 279. ">Turpie 2007</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>; <a href="./references#CD005258-bbs2-0033" title="YokoteR , MatsubaraM , HirasawaN , HagioS , IshiiK , TakataC .Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?Journal of Bone and Joint Surgery. British Volume2011;93(2):251-6. ">Yokote 2011</a>). These RCTs showed a reduction in DVT in favour of the combined treatment group; 2.21% (46/2083) in the combined treatment group compared to 3.81% (79/2076) in the IPC control group (OR 0.53, 95% CI 0.36 to 0.77; 13 RCTs, 4159 participants; P = 0.0009; <a href="./references#CD005258-fig-0024" title="">Analysis 4.2</a>). No heterogeneity was present (I<sup>2</sup> = 0%). </p> <p>Results on the secondary outcome of symptomatic DVT is shown in <a href="./references#CD005258-fig-0025" title="">Analysis 4.3</a>, with no clear effect of combined modalities. We could not estimate a difference between the effects of foot IPC and other IPC (<a href="./references#CD005258-fig-0026" title="">Analysis 4.4</a>). The risk of bleeding (<a href="./references#CD005258-fig-0027" title="">Analysis 4.5</a>), and risk of major bleeding (<a href="./references#CD005258-fig-0028" title="">Analysis 4.6</a>) was increased with combined modalities. </p> </section> <section id="CD005258-sec-0059"> <h6 class="title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only </h6> <p>Exclusion of CCTs from the analysis did not change the overall effect on either PE or DVT. Eleven RCTs evaluated the effect of combined modalities on the incidence of mostly symptomatic PE (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0020" title="RamosR , SalemBI , De PawlikowskiMP , CoordesC , EisenbergS , LeidenfrostR .The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest1996;109(1):82-5. ">Ramos 1996</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>). These RCTs showed a reduction in the incidence of PE in favour of the combined treatment group; 1.02% (30/2951) in the combined treatment group compared to 2.14% (60/2807) in the pharmacological prophylaxis control group (OR 0.45, 95% CI 0.29 to 0.70; 11 RCTs, 5758 participants; P = 0.0004; <a href="./references#CD005258-fig-0029" title="">Analysis 5.1</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>Thirteen RCTs investigated the role of combined modalities on the incidence of DVT (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>; <a href="./references#CD005258-bbs2-0005" title="CahanMA , HannaDJ , WileyLA , CoxDK , KillewichLA .External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery2000;32(3):537-43. ">Cahan 2000</a>; <a href="./references#CD005258-bbs2-0006" title="DickinsonLD , MillerLD , PatelCP , GuptaSK .Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery1998;43(5):1074–81. ">Dickinson 1998</a>; <a href="./references#CD005258-bbs2-0008" title="EdwardsJZ , PulidoPA , EzzetKA , CoppSN , WalkerRH , Colwell CW Jr.Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty2008;23(8):1122-7. ">Edwards 2008</a>; <a href="./references#CD005258-bbs2-0009" title="EiseleR , KinzlL , KoelschT .Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery - American Volume2007;89(5):1050-6. ">Eisele 2007</a>; <a href="./references#CD005258-bbs2-0014" title="LiuJW , JiangWP .Prevention of the perioperative deep venous thrombosis in hip arthroplasty. Chinese Journal of Tissue Engineering Research2017;21(31):4927-32. [DOI: 10.3969/j.issn.2095-4344.2017.31.002]">Liu 2017a</a>; <a href="./references#CD005258-bbs2-0015" title="LiuP , LiuJ , ChenL , XiaK , WuX .Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Therapeutics and Clinical Risk Management2017;13:179-83. [DOI: 10.2147/TCRM.S129077]">Liu 2017b</a>; <a href="./references#CD005258-bbs2-0021" title="ISRCTN18090286.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18090286 (first received 8 July 2016). SakaiT , IzumiM , KumagaiK , KideraK , YamaguchiT , AsaharaT , et al.Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore)2016;95(1):e2247. ">Sakai 2016</a>; <a href="./references#CD005258-bbs2-0024" title="SilbersackY , TauteBM , HeinW , PodhaiskyH .Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery - British Volume2004;86(6):809-12. ">Silbersack 2004</a>; <a href="./references#CD005258-bbs2-0025" title="SiragusaS , VicentiniL , CarboneS , BaroneM , BeltramettiC , PiovellaF .Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology1994;87 Suppl 1:186. ">Siragusa 1994</a>; <a href="./references#CD005258-bbs2-0026" title="StannardJP , HarrisRM , BucknellAL , CossiA , WardJ , ArringtonED .Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics1996;25(2):127–34. ">Stannard 1996</a>; <a href="./references#CD005258-bbs2-0031" title="WindischC , KolbW , KolbK , GrütznerP , VenbrocksR , AndersJ .Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics2011;35(7):995-1000. ">Windisch 2011</a>; <a href="./references#CD005258-bbs2-0034" title="ZhouX , GongS , LiangW , HuJ .Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer. International Journal of Clinical and Experimental Medicine2020;13(1):2717-23. ">Zhou 2020</a>). These RCTs showed a reduction in incidence of DVT in favour of the combined treatment group; 6.17% (159/2578) in the combined treatment group compared to 9.21% (239/2594) in the pharmacological prophylaxis control group (OR 0.44, 95% CI 0.22 to 0.87; 13 RCTs, 5172 participants; P = 0.02; <a href="./references#CD005258-fig-0030" title="">Analysis 5.2</a>). Substantial heterogeneity was present (I<sup>2</sup> = 80%) so we used a random‐effects model.  </p> <p>Results on the secondary outcome of symptomatic DVT are shown in <a href="./references#CD005258-fig-0031" title="">Analysis 5.3</a>, with no clear effect of combined modalities. There was no clear difference between the effects of foot IPC and other IPC (<a href="./references#CD005258-fig-0032" title="">Analysis 5.4</a>). The risk of bleeding (<a href="./references#CD005258-fig-0033" title="">Analysis 5.5</a>) and risk of major bleeding (<a href="./references#CD005258-fig-0034" title="">Analysis 5.6</a>) was similar between the two groups. </p> </section> <section id="CD005258-sec-0060"> <h6 class="title">IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only</h6> <p>Exclusion of CCTs from the analysis did not change the overall effect on either PE or DVT. Two RCTs evaluated the role of these combined modalities on the incidence of symptomatic PE (<a href="./references#CD005258-bbs2-0030" title="WestrichGH , BottnerF , WindsorRE , LaskinRS , HaasSB , SculcoTP .VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty2006;21(6 Suppl 2):139-43. ">Westrich 2006</a>; <a href="./references#CD005258-bbs2-0032" title="WoolsonST , WattJM .Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. Journal of Bone and Joint Surgery - American Volume1991;73(4):507-12. ">Woolson 1991</a>). Pooling data from these RCTs showed no clear difference in PE; 0% (0/204) in the IPC plus pharmacological prophylaxis treatment group compared to 1.00% (2/201) in the IPC plus aspirin control group (OR 0.33, 95% CI 0.03 to 3.19; 2 RCTs, 405 participants; P = 0.34; <a href="./references#CD005258-fig-0035" title="">Analysis 6.1</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> <p>The same RCTs investigated the role of combined modalities on the incidence of DVT. These showed no clear difference in DVT; 12.25% (25/204) in the IPC plus pharmacological prophylaxis treatment group compared to 14.92% (30/201) in the IPC plus aspirin control group (OR 0.79, 95% CI 0.44 to 1.39; 2 RCTs, 405 participants; P = 0.41; <a href="./references#CD005258-fig-0036" title="">Analysis 6.2</a>). Results did not demonstrate heterogeneity (I<sup>2</sup> = 0%). </p> </section> </section> <section id="CD005258-sec-0061"> <h5 class="title">Exclusion of studies with medical patients</h5> <p>Exclusion of one study (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>), with a majority of medical patients, did not alter the significance of findings of <a href="./references#CD005258-fig-0011" title="">Analysis 2.1</a> and <a href="./references#CD005258-fig-0012" title="">Analysis 2.2</a>. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005258-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005258-sec-0062"></div> <section id="CD005258-sec-0063"> <h3 class="title" id="CD005258-sec-0063">Summary of main results</h3> <p>Our review showed that combined modalities may be more effective than single modalities (anticoagulation or compression alone) in reducing the incidence of PE and incidence of DVT. The use of IPC plus pharmacological prophylaxis reduced the incidence of PE and DVT compared to IPC alone (both low‐certainty evidence). The use of IPC plus pharmacological prophylaxis also reduced incidence of PE (low‐certainty evidence) and DVT (high‐certainty evidence) when compared to pharmacological prophylaxis alone. Regarding those studies that investigated the combination of compression plus anticoagulant with compression plus aspirin, our review showed no clear difference between combined and single modalities in the incidence of PE and DVT; this was likely caused by the low number of events and can be attributed to a type II error, that is, an incorrect retention of the null hypothesis, since the results are in favour of IPC combined with anticoagulation. The addition of an anticoagulant to IPC, however, increased the risk of bleeding compared to IPC alone (very low‐certainty evidence), a side effect not observed for IPC when added to anticoagulation (very low‐certainty evidence), as indeed expected for a physical method of thromboprophylaxis. These findings highlight the need to tailor the use of additional pharmacological thromboprophylaxis in patients at low risk for bleeding or those for whom bleeding does not have catastrophic consequences. This issue deserves further study since the criteria for major bleeding were not uniform across the studies, with some of them reporting on blood loss during the procedures, or through drains, or providing rates for postoperative bleeding. We judged the certainty of the evidence for the research that supports these conclusions to be mostly of low or very low certainty as a result of bias, indirectness, and imprecision. </p> <p>The mechanism responsible for the improved effectiveness of combined modalities may be attributed to the fact that VTE is a multifactorial process. Virchow in 1856 suggested that venous stasis, coagulopathy, and endothelial injury are all causes of VTE (<a href="./references#CD005258-bbs2-0090" title="VirchowRL .Thrombosis and emboli [Phlogose und thrombose im gefässsystem]. In: Gesammelte Adhandlungen zur Wissenschaftlichen Medicine. Frankfurt am Main: von Meidinger &amp; Sohn, 1856:458-636.">Virchow 1856</a>). By treating the different causes of VTE it is expected that efficacy of DVT prevention would be improved. Rosendaal more recently extended Virchow's theory by proposing a model of risk factors, which considered the importance of the additive role and interaction of multiple risk factors (multiple‐hit model; <a href="./references#CD005258-bbs2-0085" title="RosendaalFR .Venous thrombosis: a multicausal disease. Lancet1999;353(9159):1167-73.">Rosendaal 1999</a>). Based on the additive role of mechanical and pharmacological modalities, the results of this review suggest that venous stasis and hypercoagulopathy may be independent risk factors. IPC reduces venous stasis by producing active flow enhancement (<a href="./references#CD005258-bbs2-0074" title="KakkosSK , GriffinM , GeroulakosG , NicolaidesAN .The efficacy of a new portable sequential compression device (SCD Express) in preventing venous stasis. Journal of Vascular Surgery2005;42(2):296-303.">Kakkos 2005a</a>), and also increases tissue factor pathway inhibitor (TFPI) plasma levels (<a href="./references#CD005258-bbs2-0063" title="ChouhanVD , ComerotaAJ , SunL , HaradaR , GaughanJP , RaoAK .Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arteriosclerosis, Thrombosis and Vascular Biology1999;19(11):2812-7.">Chouhan 1999</a>). Unfractionated and LMWH inhibit factor X. These totally different mechanisms of action are most likely responsible for the synergy between these two modality types. </p> <p>Subgroup analysis did not detect a difference in effectiveness between orthopaedic and non‐orthopaedic participants regarding DVT and PE prevention. No differences were detected in subgroup analysis for foot pumps compared to non‐foot pumps, likely a result of the small number of participants. </p> <p>Sensitivity analyses restricting analysis to RCTs only did not significantly alter the overall results. </p> <p>Pulmonary embolism risk‐reduction rates were mostly consistent across the studies with no heterogeneity, perhaps because symptomatic PE that was mostly reported is a clinically significant complication. In contrast, some heterogeneity was noted in the results on DVT reduction with the adjuvant use of IPC. This might have been related to the fact that the methodological quality of the assessed studies was low, and risk of bias was usually high. An alternative explanation is that the heterogeneity of the included participants who underwent various surgical procedures resulted in a variable risk of DVT. Finally, the variety of IPC devices may also account for the difference observed. </p> <p>The results of our review are in agreement with the recommendations of the venous thromboembolism prevention guidelines that certain high‐risk surgical and trauma patients should receive multimodal prophylaxis (<a href="./references#CD005258-bbs2-0061" title="Anderson DR,  Morgano GP,  Bennett C,  Dentali F,  Francis CW,  GarciaDA , et al.American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Advances2019;3(23):3898-944.">ASH 2019</a>; <a href="./references#CD005258-bbs2-0069" title="GouldMK , GarciaDA , WrenSM , KaranicolasPJ , ArcelusJI , HeitJA , et al.Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141:e227S-e277S.">Gould 2012</a>; <a href="./references#CD005258-bbs2-0079" title="National Clinical Guideline Centre - Acute and chronic conditions.Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. nice.org.uk/guidance/cg92/ (accessed April 2016).">NICE 2009</a>; <a href="./references#CD005258-bbs2-0080" title="NICE guidelines.Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. nice.org.uk/guidance/ng89 (accessed November 2021).">NICE 2018</a>; <a href="./references#CD005258-bbs2-0081" title="NicolaidesAN , FareedJ , KakkarAK , ComerotaAJ , GoldhaberSZ , HullR , et al.Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). International Angiology2013;32:111-260.">Nicolaides 2013</a>). </p> </section> <section id="CD005258-sec-0064"> <h3 class="title" id="CD005258-sec-0064">Overall completeness and applicability of evidence</h3> <p>The studies included in this review were carried out in a wide range of patient groups undergoing orthopaedic but also urological, cardiothoracic, general surgical, neurosurgical and gynaecological procedures, and trauma patients. Most of the participants had a high‐risk procedure or condition and, therefore, the results of this review are not necessarily applicable to different patient groups, where a much lower risk may reduce the absolute risk reduction with combined modalities. </p> <p>In an effort to investigate the applicability of combined modalities in orthopaedic and non‐orthopaedic participants, we performed subgroup analysis. This confirmed the efficacy of adding compression to anticoagulation in orthopaedic patients (and also non‐orthopaedic patients regarding PE), and the efficacy of adding anticoagulation to compression in non‐orthopaedic patients; these results indicate a need for further research in particular patient populations. Since studies on combined modalities are mostly performed in participants at high risk for VTE, the absolute benefit that would be observed is expected to be much lower in moderate‐risk patients, calling for cost‐effectiveness calculations and studies. </p> <p>Additionally, it should be noted that the various IPC types may not have the same effectiveness and should not be used interchangeably, for example, foot pumps versus calf or calf and thigh leggings. </p> <p>A potential confounding factor in the present review is the concurrent use of elastic stockings, very often used together with IPC. </p> <p>Also, it should be mentioned that medical (non‐surgical) participants were only a small fraction of patients included in the present review (<a href="./references#CD005258-bbs2-0001" title="ArabiY , Al-HameedF , BurnsKE , MehtaS , AlsolamyS , AlmaaniM , et al.Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials2018;19(1):182. [DOI: 10.1186/s13063-018-2534-6]ArabiYM , Al-HameedF , BurnsKE , MehtaS , AlsolamySJ , AlshahraniMS , et al.Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine2019;380(14):1305-15. ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial [Trials,17 (2016) (390)]. Trials2016;17:420. [DOI: 10.1186/s13063-016-1556-1]ArabiYM , AlsolamyS , Al-DawoodA , Al-OmariA , Al-HameedF , BurnsKE , et al.Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17(1):390. [DOI: 10.1186/s13063-016-1520-0]ISRCTN44653506.The PREVENT trial: pneumatic compression for preventing venous thromboembolism. who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44653506 (first received 14 July 2014). NCT02040103.Pneumatic compression for preventing venous thromboembolism (PREVENT). clinicaltrials.gov/show/NCT02040103 (first received 20 January 2014). ">Arabi 2019</a>), where IPC was found ineffective in reducing further PE and DVT. </p> <p>Reporting of bleeding outcomes (major and minor bleeding) was not uniform across the studies, with some studies reporting on blood loss during the procedures or through the drains or providing rates for postoperative bleeding. The definitions used were also not uniform. This issue deserves further study. </p> </section> <section id="CD005258-sec-0065"> <h3 class="title" id="CD005258-sec-0065">Quality of the evidence</h3> <p>This review included some 14,931 participants who were studied in 34 studies (26 RCTs). This provided a body of evidence to investigate our hypothesis that combined modalities are more effective than their single counterparts. However, risk for performance bias was high in most studies, and risk for selection and detection bias was mostly unclear or high. Nevertheless, the results of the present meta‐analysis update are generally consistent with a low amount of heterogeneity in almost all comparisons. </p> <p>Using GRADE assessment, the certainty of evidence for DVT and PE prevention with combined modalities varied from high to low. See <a href="./full#CD005258-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD005258-tbl-0002">summary of findings Table 2</a>. Risk of bias and imprecision accounted for downgrading, with the exception of the outcome of DVT, where the risk of bias was counteracted by a large treatment effect, in combination with a lack of imprecision. </p> <p>The certainty of the evidence for bleeding and major bleeding for the comparison combined modalities versus IPC is very low. In addition to risk of bias and imprecision, we downgraded the certainty of the evidence for indirectness as definitions of bleeding and the reporting of bleeding outcomes was not uniform across studies. The certainty of the evidence for bleeding and major bleeding for the comparison combined modalities versus pharmacological prophylaxis was also very low. We downgraded the certainty of the evidence for risk of bias, indirectness (because the definition of bleeding and reporting of bleeding outcomes was not uniform across studies) and imprecision (due to the small number of participants and few events, and also wide confidence intervals). </p> </section> <section id="CD005258-sec-0066"> <h3 class="title" id="CD005258-sec-0066">Potential biases in the review process</h3> <p>The review authors have made an enormous effort to identify potential studies for inclusion in the present review. Publication bias still could have limited the validity of our results. </p> <p>This review set out to assess RCTs and CCTs. Many of the CCTs are old and the reporting of the study methodology is often poor. In addition, patient care and standard practice has changed considerably over time. When assessing the incidence of DVT and PE in RCTs only, the overall direction and size of the effects were not affected. This was likely caused by the fact that many CCTs did not contribute to the analysis due to small number of reported events. However, when sufficient RCTs become available to perform meaningful analyses of the planned subgroups we will consider including RCTs only. </p> <p>The review assessed symptomatic or asymptomatic DVT and symptomatic PE as outcomes. In future updates, data permitting, we will add proximal DVT and clinically important VTE (proximal DVT and symptomatic PE) as additional important outcomes. </p> <p>In order to be as inclusive as possible and because not all studies reported on the type of IPC devices used, we included all IPC devices. This resulted in including some devices that may no longer be used in some parts of the world. </p> <p>We performed no formal assessment of side effects of IPC. However, from the included studies we note these were rarely encountered and recorded by the studies. We will look into this in more detail in future updates. </p> </section> <section id="CD005258-sec-0067"> <h3 class="title" id="CD005258-sec-0067">Agreements and disagreements with other studies or reviews</h3> <p>The results presented here agree with previous systematic meta‐analyses on this topic, which showed that combined modalities are better than single prophylactic modalities (<a href="./references#CD005258-bbs2-0073" title="HoKM , TanJA .Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation2013;128:1003-20.">Ho 2013</a>; <a href="./references#CD005258-bbs2-0075" title="KakkosSK , WarwickD , NicolaidesAN , StansbyGP , TsolakisIA .Combined (mechanical and pharmacological) modalities for VTE prevention in joint arthroplasty. Journal of Bone and Joint Surgery. British Volume2012;94-B:729-34.">Kakkos 2012</a>; <a href="./references#CD005258-bbs2-0087" title="SobierajDM , ColemanCI , TongbramV , ChenW , ColbyJ , LeeS , et al.Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy2013;33(3):275–83.">Sobieraj 2013</a>; <a href="./references#CD005258-bbs2-0091" title="ZarebaP , WuC , AgzarianJ , RodriguezD , KearonC .Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery. British Journal of Surgery2014;101:1053–62.">Zareba 2014</a>). The studies included in these reviews were mostly restricted to a particular patient category or were limited by the fact that they used IPC interchangeably with elastic stockings, which is a limitation when interpretation of the results is attempted. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005258-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD005258-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD005258-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD005258-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 1: Incidence of PE ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 1: Incidence of PE ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 2: Incidence of PE ‐ foot IPC or other IPC" data-id="CD005258-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 2: Incidence of PE ‐ foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 3: Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 3: Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 4: Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 4: Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 5: Incidence of DVT ‐ by foot IPC or other IPC" data-id="CD005258-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 5: Incidence of DVT ‐ by foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 6: Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 6: Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 7: Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: IPC plus pharmacological prophylaxis versus IPC alone, Outcome 7: Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 1: Incidence of PE ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 1: Incidence of PE ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 2: Incidence of PE ‐ foot IPC or other IPC" data-id="CD005258-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 2: Incidence of PE ‐ foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 3: Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 3: Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 4: Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 4: Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 5: Incidence of DVT ‐ foot IPC or other IPC" data-id="CD005258-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 5: Incidence of DVT ‐ foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 6: Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 6: Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 7: Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients" data-id="CD005258-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone, Outcome 7: Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 1: Incidence of PE" data-id="CD005258-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 1: Incidence of PE </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 2: Incidence of DVT" data-id="CD005258-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 2: Incidence of DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 3: Incidence of symptomatic DVT" data-id="CD005258-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 3: Incidence of symptomatic DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 4: Incidence of bleeding" data-id="CD005258-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 4: Incidence of bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 5: Incidence of major bleeding" data-id="CD005258-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: IPC plus pharmacological prophylaxis versus IPC plus aspirin, Outcome 5: Incidence of major bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 1: Incidence of PE" data-id="CD005258-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 1: Incidence of PE </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 2: Incidence of DVT" data-id="CD005258-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 2: Incidence of DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 3: Incidence of symptomatic DVT" data-id="CD005258-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 3: Incidence of symptomatic DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 4: Incidence of DVT by foot IPC or other IPC" data-id="CD005258-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 4: Incidence of DVT by foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 5: Incidence of bleeding" data-id="CD005258-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 5: Incidence of bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 6: Incidence of major bleeding" data-id="CD005258-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only, Outcome 6: Incidence of major bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 1: Incidence of PE" data-id="CD005258-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 1: Incidence of PE </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 2: Incidence of DVT" data-id="CD005258-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 2: Incidence of DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 3: Incidence of symptomatic DVT" data-id="CD005258-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 3: Incidence of symptomatic DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 4: Incidence of DVT by foot IPC or other IPC" data-id="CD005258-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 4: Incidence of DVT by foot IPC or other IPC </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 5: Incidence of bleeding" data-id="CD005258-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 5: Incidence of bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 6: Incidence of major bleeding" data-id="CD005258-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only, Outcome 6: Incidence of major bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only, Outcome 1: Incidence of PE" data-id="CD005258-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only, Outcome 1: Incidence of PE </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005258-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/urn:x-wiley:14651858:media:CD005258:CD005258-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only, Outcome 2: Incidence of DVT" data-id="CD005258-fig-0036" src="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_t/tCD005258-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only, Outcome 2: Incidence of DVT </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/media/CDSR/CD005258/image_n/nCD005258-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005258-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Does combined intermittent pneumatic compression (IPC) plus pharmacological prophylaxis increase prevention of venous thromboembolism compared with IPC alone?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing surgery or at risk of developing VTE due to surgery, trauma or ICU stay </p> <p><b>Settings:</b> hospital  </p> <p><b>Intervention:</b> combined modalities ‐  IPC plus pharmacological prophylaxis </p> <p><b>Comparison:</b> IPC alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects <sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with IPC alone</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with combined modalities</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of PE</b><sup>a</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> (4 to 12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.51</b> (0.29 to 0.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5462 (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of DVT</b><sup>c</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> (14 to 28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.51</b> (0.36 to 0.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5394 (18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of bleeding</b><sup>d</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 1000</b> (36 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 6.02</b> (3.88 to 9.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4634 (13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b><sup>f</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> (10 to 39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 5.77</b> (2.81 to 11.83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4133 (12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval;<b>DVT:</b> deep vein thrombosis;<b>ICU:</b> intensive care unit; <b>IPC:</b> intermittent pneumatic compression; <b>OR:</b> odds ratio; <b>PE:</b> pulmonary embolism; <b>VTE:</b> venous thromboembolism </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.  </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Pulmonary embolism assessed by pulmonary angiography or scintigraphy, computed tomography (CT), angiography, or autopsy.<br/><sup>b</sup>Downgraded by two levels due to risk of bias concerns (high in one or more domains regarding all but one study) and due to imprecision as a result of a small number of overall events.<br/><sup>c</sup>Deep vein thrombosis assessed by ascending venography, I‐125 fibrinogen uptake test, and ultrasound scanning.<br/><sup>d</sup> Any type of bleeding as described by the study authors.<br/><sup>e</sup>Downgraded by three levels due to risk of bias concerns (high in one or more domains regarding all but one study), due to imprecision as a result of a small number of events overall, and indirectness because bleeding definitions were not uniform across the studies.<br/><sup>f</sup>Major bleeding as defined by the study authors, but usually located at the surgical site or in a critical organ or site, requiring intervention or transfusion of at least units of blood, or leading to death. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005258-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Does combined intermittent pneumatic compression (IPC) plus pharmacological prophylaxis increase prevention of venous thromboembolism compared with pharmacological prophylaxis alone?</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing surgery or at risk of developing VTE because of surgery, trauma or ICU stay </p> <p><b>Settings:</b> hospital  </p> <p><b>Intervention:</b> combined modalities ‐ IPC plus pharmacological prophylaxis </p> <p><b>Comparison:</b> pharmacological prophylaxis alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects <sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with pharmacological prophylaxis alone</b> </p> <p><b> </b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with combined modalities</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of PE</b><sup>a</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> (6 to 13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.46</b> (0.30 to 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6737 (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of DVT</b><sup>c</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> (21 to 67) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.38</b> (0.21 to 0.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6151 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>High</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of bleeding</b><sup>e</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> (43 to 98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.87</b> (0.56 to 1.35 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1314 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b><sup>g</sup> </p> <p><b>(early postoperative period)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>13 per 1000</b> (4 to 44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.21</b> (0.35 to 4.18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>908 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very <b>low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval;<b>DVT:</b> deep vein thrombosis;<b>ICU:</b> intensive care unit; <b>IPC:</b> intermittent pneumatic compression; <b>OR:</b> odds ratio; <b>PE:</b> pulmonary embolism; <b>VTE:</b> venous thromboembolism </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Pulmonary embolism assessed by pulmonary angiography or scintigraphy, computed tomography (CT), angiography, single photon emission CT (SPECT) or autopsy.<br/><sup>b</sup>Downgraded by two levels due to risk of bias (which was high in one or more domains regarding all studies) and due to imprecision as a result of a small number of events overall.<br/><sup>c</sup>Deep vein thrombosis assessed predominantly by ascending venography, I‐125 fibrinogen uptake test, and ultrasound scanning.<br/><sup>d</sup>Downgraded by one level due to risk of bias (which was high in one or more domains regarding all but one study) and upgraded by one level because of a large magnitude of the effect.<br/><sup>e</sup>Any type of bleeding as described by the study authors.<br/><sup>f</sup>Downgraded by three levels due to risk of bias (which was high in one or more domains regarding all studies), due to imprecision as a result of a small number of events overall and a wide confidence interval, and indirectness because bleeding definitions were not uniform across the studies.<br/><sup>g</sup>Major bleeding as defined by the study authors, but usually located at the surgical site or in a critical organ or site, requiring intervention or transfusion of at least units of blood, or leading to death. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/full#CD005258-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Incidence of PE ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.29, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.29, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Incidence of PE ‐ foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.29, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.29, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.38, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.31, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.21, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.06, 37.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3839</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.19, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Incidence of DVT ‐ by foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.02 [3.88, 9.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.79 [0.77, 10.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.61 [4.14, 10.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.77 [2.81, 11.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [0.13, 83.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.91 [2.83, 12.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Incidence of PE ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.30, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.08, 4.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.29, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Incidence of PE ‐ foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.30, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.30, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Incidence of DVT ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.21, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3076</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.13, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Incidence of symptomatic DVT ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3032</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.34, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [0.38, 11.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.18, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Incidence of DVT ‐ foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.05, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3824</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.17, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Incidence of bleeding ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.56, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.20, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.57, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Incidence of major bleeding ‐ orthopaedic and non‐orthopaedic patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>908</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.35, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.21, 5.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Non‐orthopaedic patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.21, 9.49]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC plus aspirin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Incidence of PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>605</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.03, 3.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Incidence of DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>605</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.48, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Incidence of symptomatic DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Incidence of bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.27, 5.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.15, 4.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC plus aspirin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Incidence of PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.28, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Incidence of DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Incidence of symptomatic DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.15, 9.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Incidence of DVT by foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5085</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.36, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.36, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Incidence of bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.45 [3.38, 8.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.90 [2.82, 12.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC alone ‐ RCTs only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Incidence of PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.29, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Incidence of DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.22, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Incidence of symptomatic DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.29, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Incidence of DVT by foot IPC or other IPC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.23, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Foot IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.05, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 Other IPC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.20, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Incidence of bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.30, 2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.35, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus pharmacological prophylaxis alone ‐ RCTs only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005258-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Incidence of PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.03, 3.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Incidence of DVT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.44, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">IPC plus pharmacological prophylaxis versus IPC plus aspirin ‐ RCTs only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005258.pub4/references#CD005258-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005258.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005258-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005258-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005258-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005258-note-0011">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD005258-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD005258-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD005258-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005258-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005258-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005258\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005258\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005258\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005258\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005258\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005258.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005258.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005258.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005258.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005258.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715347560"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005258.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715347564"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005258.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d84e03e11f446',t:'MTc0MDcxNTM0Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 